The following discussion should be read in conjunction with our consolidated
financial statements and related notes and other financial information appearing
elsewhere in this Annual Report on Form 10-K. In addition to historical
information, the following discussion and other parts of this Annual Report
contain forward-looking information that involves risks and uncertainties. Our
actual results could differ materially from those anticipated by such
forward-looking information due to the factors discussed under Part I. Item 1A.
"Risk Factors" and "Note about Forward-Looking Statements" appearing elsewhere
herein.


The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Annual Report on Form 10-K involve risks and uncertainties, including statements as to:

? our future operating results and the impact of COVID-19 pandemic thereon;

? the introduction, withdrawal, success and timing of business initiatives and


   strategies;




? changes in political, economic or industry conditions, the interest rate

environment or financial and capital markets, which could result in changes in

the value of our assets;

? pandemics or other serious public health events, such as the recent global


   outbreak of COVID-19;




? the relative and absolute investment performance and operations of our Manager;

? the impact of increased competition;

? our ability to turn potential investment opportunities into transactions and

thereafter into completed and successful investments;

? the unfavorable resolution of any future legal proceedings;

? our business prospects and the prospects of our portfolio companies, including

our and their ability to achieve our respective objectives vis a vie the


   current COVID-19 pandemic;



? the impact of investments that we expect to make and future acquisitions and


   divestitures;




? our contractual arrangements and relationships with third parties;

? the dependence of our future success on the general economy and its impact on

the industries in which we invest and the impact of the COVID-19 pandemic


   thereon;




? the ability of our portfolio companies to achieve their objectives;

? our expected financings and investments;

? our regulatory structure and tax status, including our ability to operate as a

business development company ("BDC"), or to operate our small business

investment company ("SBIC") subsidiaries, and to continue to qualify to be

taxed as a regulated investment company ("RIC");

? the adequacy of our cash resources and working capital;

? the timing of cash flows, if any, from the operations of our portfolio

companies and the impact of the COVID-19 pandemic thereon;






                                       75




? the impact of interest rate volatility on our results, particularly because we

use leverage as part of our investment strategy;

? the impact of legislative and regulatory actions and reforms and regulatory,

supervisory or enforcement actions of government agencies relating to us or our


   Manager;




? the impact of changes to tax legislation and, generally, our tax position;

? our ability to access capital and any future financings by us;

? the ability of our Manager to attract and retain highly talented professionals;


   and



? the ability of our Manager to locate suitable investments for us and to monitor

and effectively administer our investments and the impacts of the COVID-19


   pandemic thereon.




Such forward-looking statements may include statements preceded by, followed by
or that otherwise include terms such as "anticipate," "believe," "could,"
"estimate," "expect," "intend," "may," "plan," "potential," "project," "should,"
"will" and "would" or the negative of these terms or other comparable
terminology.



We have based the forward-looking statements included in this annual report on
Form 10-K on information available to us on the date of this annual report on
Form 10-K, and we assume no obligation to update any such forward-looking
statements. Actual results could differ materially from those anticipated in our
forward-looking statements, and future results could differ materially from
historical performance. We undertake no obligation to revise or update any
forward-looking statements, whether as a result of new information, future
events or otherwise, unless required by law or SEC rule or regulation. You are
advised to consult any additional disclosures that we may make directly to you
or through reports that we in the future may file with the U.S. Securities and
Exchange Commission (the "SEC"), including annual reports on Form 10-K,
quarterly reports on Form 10-Q and current reports on Form 8-K.



The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this annual report on Form 10-K.





OVERVIEW



We are a Maryland corporation that has elected to be treated as a BDC under the
Investment Company Act of 1940, as amended (the "1940 Act"). Our investment
objective is to create attractive risk-adjusted returns by generating current
income and long-term capital appreciation from our investments. We invest
primarily in senior and unitranche leveraged loans and mezzanine debt issued by
private U.S. middle market companies, which we define as companies having
earnings before interest, tax, depreciation and amortization ("EBITDA") of
between $2 million and $50 million, both through direct lending and through
participation in loan syndicates. We may also invest up to 30.0% of the
portfolio in opportunistic investments in order to seek to enhance returns to
stockholders. Such investments may include investments in distressed debt, which
may include securities of companies in bankruptcy, foreign debt, private equity,
securities of public companies that are not thinly traded and structured finance
vehicles such as collateralized loan obligation funds. Although we have no
current intention to do so, to the extent we invest in private equity funds, we
will limit our investments in entities that are excluded from the definition of
"investment company" under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act,
which includes private equity funds, to no more than 15.0% of its net assets. We
have elected and qualified to be treated as a RIC under Subchapter M of the
Internal Revenue Code of 1986, as amended (the "Code").



Corporate History



We commenced operations, at the time known as GSC Investment Corp., on March 23,
2007 and completed an initial public offering of shares of common stock on March
28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP
(NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the
consummation of a recapitalization transaction on July 30, 2010, as described
below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our
investment adviser and changed our name to Saratoga Investment Corp.



                                       76





As a result of the event of default under a revolving securitized credit
facility with Deutsche Bank we previously had in place, in December 2008 we
engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate
strategic transaction opportunities and consider alternatives for us. On April
14, 2010, GSC Investment Corp. entered into a stock purchase agreement with
Saratoga Investment Advisors and certain of its affiliates and an assignment,
assumption and novation agreement with Saratoga Investment Advisors, pursuant to
which GSC Investment Corp. assumed certain rights and obligations of Saratoga
Investment Advisors under a debt commitment letter Saratoga Investment Advisors
received from Madison Capital Funding LLC, which indicated Madison Capital
Funding's willingness to provide GSC Investment Corp. with a $40.0 million
senior secured revolving credit facility, subject to the satisfaction of certain
terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P.
entered into a termination and release agreement, to be effective as of the
closing of the transaction contemplated by the stock purchase agreement,
pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and
all accrued and unpaid deferred incentive management fees up to and as of the
closing of the transaction contemplated by the stock purchase agreement but
continued to be entitled to receive the base management fees earned through the
date of the closing of the transaction contemplated by the stock purchase
agreement.



On July 30, 2010, the transactions contemplated by the stock purchase agreement
with Saratoga Investment Advisors and certain of its affiliates were completed,
the private sale of 986,842 shares of our common stock for $15.0 million in
aggregate purchase price to Saratoga Investment Advisors and certain of its
affiliates closed, the Company entered into the Credit Facility, and the Company
began doing business as Saratoga Investment Corp.



We used the net proceeds from the private sale transaction and a portion of the
funds available to us under the Credit Facility to pay the full amount of
principal and accrued interest, including default interest, outstanding under
our revolving securitized credit facility with Deutsche Bank. The revolving
securitized credit facility with Deutsche Bank was terminated in connection with
our payment of all amounts outstanding thereunder on July 30, 2010.



On August 12, 2010, we effected a one-for-ten reverse stock split of our
outstanding common stock. As a result of the reverse stock split, every ten
shares of our common stock were converted into one share of our common stock.
Any fractional shares received as a result of the reverse stock split were
redeemed for cash. The total cash payment in lieu of shares was $230.
Immediately after the reverse stock split, we had 2,680,842 shares of our common
stock outstanding.


In January 2011, we registered for public resale of the 986,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.





On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC,
LP ("SBIC LP"), received an SBIC license from the Small Business Administration
("SBA"). On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment
Corp. SBIC II LP ("SBIC II LP"), also received an SBIC license from the SBA.



In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50%
fixed-rate unsecured notes due 2020 (the "2020 Notes") for net proceeds of $46.1
million after deducting underwriting commissions of $1.9 million and offering
costs of $0.3 million. The proceeds included the underwriters' full exercise of
their overallotment option. The 2020 Notes were listed on the NYSE under the
trading symbol "SAQ" with a par value of $25.00 per share. The 2020 Notes were
redeemed in full on January 13, 2017 and are no longer listed on the NYSE.



On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg
Thalmann & Co. through which we may offer for sale, from time to time, up to
$20.0 million in aggregate principal amount of the 2020 Notes through an
At-the-Market ("ATM") offering. Prior to the 2020 Notes being redeemed in full,
the Company sold 539,725 bonds with a principal of $13.5 million at an average
price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction
costs).



On December 21, 2016, we issued $74.5 million in aggregate principal amount of
our 6.75% fixed-rate unsecured notes due 2023 (the "2023 Notes") for net
proceeds of $71.7 million after deducting underwriting commissions of
approximately $2.3 million and offering costs of approximately $0.5 million. The
issuance included the exercise of substantially all of the underwriters' option
to purchase an additional $9.8 million aggregate principal amount of 2023 Notes
within 30 days. The 2023 Notes were listed on the NYSE under the trading symbol
"SAB" with a par value of $25.00 per share. On December 21, 2019 and February 7,
2020, the Company redeemed $50.0 million and $24.45 million, respectively, in
aggregate principal amount of the $74.45 million in aggregate principal amount
of issued and outstanding 2023 Notes.



                                       77





On March 16, 2017, we entered into an equity distribution agreement with
Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to
time, up to $30.0 million of our common stock through an ATM offering.
Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added
to the agreement. On July 9, 2019, the amount of the common stock to be offered
through this offering was increased to $70.0 million, and on October 8, 2019,
the amount of the common stock to be offered was increased to $130.0 million. As
of February 28, 2021, the Company sold 3,922,018 shares for gross proceeds of
$97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9
million (net of transaction costs). For the year ended February 28, 2021, there
was no activity related to the ATM offerings.



On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced
at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75
million. The net proceeds, after deducting underwriting commissions of $1.15
million and offering costs of approximately $0.2 million, amounted to
approximately $27.4 million. The Company also granted the underwriters a 30-day
option to purchase up to an additional 172,500 shares of its common stock,

which
was not exercised.



On August 7, 2018, we entered into an unsecured loan agreement ("CLO 2013-1
Warehouse Loan") with Saratoga Investment Corp. CLO 2013-1 Warehouse, Ltd ("CLO
2013-1 Warehouse"), a wholly-owned subsidiary of Saratoga Investment Corp. CLO
2013-1, Ltd. ("Saratoga CLO"), pursuant to which CLO 2013-1 Warehouse may borrow
from time to time up to $20 million from us in order to provide capital
necessary to support warehouse activities. The CLO 2013-1 Warehouse Loan, which
expired on February 7, 2020, bears interest at an annual rate of 3M USD LIBOR +
7.5%. During the year ended February 28, 2019, the maximum amount invested by us
in the CLO 2013-1 Warehouse Loan amounted to $20.0 million.



On August 28, 2018, the Company issued $40.0 million in aggregate principal
amount of our 6.25% fixed-rate notes due 2025 (the "6.25% 2025 Notes") for net
proceeds of $38.7 million after deducting underwriting commissions of
approximately $1.3 million. Offering costs incurred were approximately $0.3
million. The issuance included the full exercise of the underwriters' option to
purchase an additional $5.0 million aggregate principal amount of 6.25% 2025
Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in
arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25%
per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31,
2025 and commencing August 31, 2021, may be redeemed in whole or in part at any
time or from time to time at our option. The net proceeds from the offering were
used for general corporate purposes in accordance with our investment objective
and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes
have been capitalized and are being amortized over the term of the 6.25% 2025
Notes.



On December 14, 2018, the Company completed the third refinancing of the
Saratoga CLO (the "2013-1 Reset CLO Notes"). This refinancing, among other
things, extended the Saratoga CLO reinvestment period to January 2021, and
extended its legal maturity to January 2030. A non-call period of January 2020
was also added. In addition to and as part of the refinancing, the Saratoga CLO
has also been upsized from $300 million in assets to approximately $500 million.
As part of this refinancing and upsizing, the Company invested an additional
$13.8 million in all of the newly issued subordinated notes of the Saratoga CLO,
and purchased $2.5 million in aggregate principal amount of the Class F-R-2
Notes tranche and $7.5 million in aggregate principal amount of the Class G-R-2
Notes tranche at par. Concurrently, the existing $4.5 million of Class F notes
and $20.0 million CLO 2013-1 Warehouse Loan were repaid.



On February 5, 2019, the Company completed a re-opening and up-sizing of its
existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate
principal amount for net proceeds of $19.2 million after deducting underwriting
commissions of approximately $0.6 million and discount of $0.2 million. Offering
costs incurred were approximately $0.2 million. The issuance included the full
exercise of the underwriters' option to purchase an additional $2.5 million
aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate,
interest payment dates and maturity remain unchanged from the existing 6.25%
2025 Notes issued in August 2018. The net proceeds from this offering were used
for general corporate purposes in accordance with our investment objective and
strategies. The financing costs and discount of $1.0 million related to the
6.25% 2025 Notes have been capitalized and are being amortized over the term of
the 6.25% 2025 Notes. At February 28, 2021, the total 6.25% 2025 Notes
outstanding was $60.0 million. The 6.25% 2025 Notes are listed on the NYSE under
the trading symbol "SAF" with a par value of $25.00 per share.



On August 14, 2019, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC
II LP ("SBIC II LP"), also received an SBIC license from the SBA. The new
license will provide up to $175.0 million in additional long-term capital in the
form of SBA debentures.



                                       78





On June 24, 2020, the Company issued $37.5 million in aggregate principal amount
of our 7.25% fixed-rate notes due 2025 (the "7.25% 2025 Notes") for net proceeds
of $36.3 million after deducting underwriting commissions of approximately $1.2
million. Offering costs incurred were approximately $0.3 million. On July 6,
2020, the underwriters exercised their option in full to purchase an additional
$5.625 million in aggregate principal amount of its 7.25% unsecured notes due
2025. Net proceeds to the Company were $5.4 million after deducting underwriting
commissions of approximately $0.2 million. Interest on the 7.25% 2025 Notes is
paid quarterly in arrears on February 28, May 31, August 31 and November 30, at
a rate of 7.25% per year, beginning August 31, 2020. The 7.25% 2025 Notes mature
on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in
part at any time or from time to time at our option. The net proceeds from the
offering were used for general corporate purposes in accordance with our
investment objective and strategies. Financing costs of $1.6 million related to
the 7.25% 2025 Notes have been capitalized and are being amortized over the term
of the 7.25% 2025 Notes. The Company has received an investment grade private
rating of "BBB" from Egan-Jones Ratings Company, an independent, unaffiliated
rating agency. As of February 28, 2021, the total 7.25% 2025 Notes outstanding
was $43.1 million. The 7.25% 2025 Notes are listed on the NYSE under the trading
symbol "SAK" with a par value of $25.00 per share.



On July 9, 2020, the Company issued $5.0 million aggregate principal amount of
our 7.75% fixed-rate Notes due in 2025 (the "7.75% 2025 Notes") for net proceeds
of $4.8 million after deducting underwriting commissions of approximately $0.2
million. Offering costs incurred were approximately $0.1 million. Interest on
the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August
31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The
7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part
at any time or from time to time at our option. The net proceeds from the
offering were used for general corporate purposes in accordance with our
investment objective and strategies. Financing costs of $0.3 million related to
the 7.75% Notes 2025 have been capitalized and are being amortized over the term
of the Notes. As of February 28, 2021, the total 7.25% 2025 Notes outstanding
was $5.0 million. The 7.75% 2025 Notes are unlisted and have a par value of
$25.00 per share.



On December 29, 2020, the Company issued $5.0 million aggregate principal amount
of our 6.25% fixed-rate Notes due in 2027 (the "6.25% Notes 2027"). Offering
costs incurred were approximately $0.1 million. Interest on the 6.25% Notes 2027
is paid quarterly in arrears on February 28, May 31, August 31 and November 30,
at a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027
mature on December 29, 2027 and may be redeemed in whole or in part at any time
or from time to time at our option, on or after December 29, 2024. The net
proceeds from the offering were used for general corporate purposes in
accordance with our investment objective and strategies. Financing costs of
$0.1 million related to the 6.25% Notes 2027 have been capitalized and are being
amortized over the term of the Notes. The 6.25% 2027 Notes are unlisted and have
a par value of $25.00 per share.



On January 28, 2021, the Company issued $10.0 million aggregate principal amount
of our 6.25% fixed rate Notes due in 2027 (the "Second 6.25% Notes 2027") for
net proceeds of $9.7 million after deducting underwriting commissions of
approximately $0.3 million. Offering costs incurred were approximately $0.0
million. Interest on the Second 6.25% Notes 2027 is paid quarterly in arrears on
February 28, May 31, August 31 and November 30, at a rate of 6.25% per year,
beginning February 28, 2021. The Second 6.25% Notes 2027 mature on January 28,
2027 and commencing January 28, 2023, may be redeemed in whole or in part at any
time or from time to time at our option. The net proceeds from the offering were
used for general corporate purposes in accordance with our investment objective
and strategies. Financing costs of $0.3 million related to the Second 6.25%
Notes 2027 have been capitalized and are being amortized over the term of the
Notes. The Second 6.25% 2027 Notes are unlisted and have a par value of $25.00
per share.



On February 26, 2021, the Company completed the fourth refinancing of the
Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO
reinvestment period to April 2024, and extended its legal maturity to April
2033. A non-call period ending February 2022 was also added. In addition, and as
part of the refinancing, the Saratoga CLO has also been upsized from $500
million in assets to approximately $650 million. As part of this refinancing and
upsizing, the Company invested an additional $14.0 million in all of the newly
issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in
aggregate principal amount of the Class F-R-3 Notes tranche at par.
Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of
Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The
Company also paid $2.6 million of transaction costs related to the refinancing
and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity
distributions. As of February 28, 2021, there remained an outstanding receivable
of $2.6 million for such transaction costs which is presented as due from
affiliate on the Company's consolidated statement of assets and liabilities.



                                       79





COVID-19



On March 11, 2020, the World Health Organization declared the novel coronavirus,
or COVID-19, as a pandemic, and on March 13, 2020 the United States declared a
national emergency with respect to COVID-19. The outbreak of COVID-19 has
severely impacted global economic activity and caused significant volatility and
negative pressure in financial markets. The global impact of the outbreak has
been rapidly evolving and many countries, including the United States, have
reacted by instituting quarantines, restricting travel and hospitality, and
temporarily closing our limiting operations at many corporate offices, retail
stores, restaurants, fitness clubs and manufacturing facilities and factories in
affected jurisdictions. Such actions are creating disruption in global supply
chains and adversely impacting a number of industries. The outbreak could have a
continued adverse impact on economic and market conditions and trigger a period
of global economic slowdown. The rapid development and fluidity of this
situation precludes any prediction as to the ultimate adverse impact
of COVID-19. Nevertheless, COVID-19 presents material uncertainty and risks with
respect to the underlying value of the Company's portfolio companies, the
Company's business, financial condition, results of operations and cash flows,
such as the potential negative impact to financing arrangements, company
decisions to delay, defer and/or modify the character of dividends in order to
preserve liquidity, increased costs of operations, changes in law and/or
regulation, and uncertainty regarding government and regulatory policy.



We have evaluated subsequent events from February 28, 2021 through May 5, 2021.
However, as the discussion in this Item 7. Management's Discussion and Analysis
of Financial Condition and Results of Operations relates to the Company's
financial statements for the fiscal year end February 28, 2021, the analysis
contained herein may not fully account for impacts relating to
the COVID-19 pandemic. In that regard, for example, as of February 28, 2021, the
Company valued its portfolio investments in conformity with U.S. GAAP based on
the facts and circumstances known by the Company at that time, or reasonably
expected to be known at that time. Due to the overall volatility that
the COVID-19 pandemic has caused during the months that followed our
February 28, 2021 valuation, any valuations conducted now or in the future in
conformity with U.S. GAAP could result in a lower fair value of our portfolio.
The potential impact to our results going forward will depend to a large extent
on future developments and new information that may emerge regarding the
duration and severity of COVID-19 and the actions taken by authorities and other
entities to contain the coronavirus or treat its impact, all of which are beyond
our control. Accordingly, the Company cannot predict the extent to which its
financial condition and results of operations will be affected at this time.



Critical Accounting Policies



Basis of Presentation



The preparation of financial statements in accordance with U.S. generally
accepted accounting principles ("U.S. GAAP") requires management to make certain
estimates and assumptions affecting amounts reported in the Company's
consolidated financial statements. We have identified investment valuation,
revenue recognition and the recognition of capital gains incentive fee expense
as our most critical accounting estimates. We continuously evaluate our
estimates, including those related to the matters described below. These
estimates are based on the information that is currently available to us and on
various other assumptions that we believe to be reasonable under the
circumstances. Actual results could differ materially from those estimates under
different assumptions or conditions. A discussion of our critical accounting
policies follows.



Investment Valuation



The Company accounts for its investments at fair value in accordance with the
Financial Accounting Standards Board ("FASB") Accounting Standards Codification
("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820"). ASC 820
defines fair value, establishes a framework for measuring fair value,
establishes a fair value hierarchy based on the quality of inputs used to
measure fair value and enhances disclosure requirements for fair value
measurements. ASC 820 requires the Company to assume that its investments are to
be sold or its liabilities are to be transferred at the balance sheet date in
the principal market to independent market participants, or in the absence of a
principal market, in the most advantageous market, which may be a hypothetical
market. Market participants are defined as buyers and sellers in the principal
or most advantageous market that are independent, knowledgeable, and willing and
able to transact.



                                       80





Investments for which market quotations are readily available are fair valued at
such market quotations obtained from independent third-party pricing services
and market makers subject to any decision by our board of directors to approve a
fair value determination to reflect significant events affecting the value of
these investments. We value investments for which market quotations are not
readily available at fair value as approved, in good faith, by our board of
directors based on input from Saratoga Investment Advisors, the audit committee
of our board of directors and a third party independent valuation firm. We use
multiple techniques for determining fair value based on the nature of the
investment and experience with those types of investments and specific portfolio
companies. The selections of the valuation techniques and the inputs and
assumptions used within those techniques often require subjective judgements and
estimates. These techniques include market comparables, discounted cash flows
and enterprise value waterfalls. Fair value is best expressed as a range of
values from which the Company determines a single best estimate. The types of
inputs and assumptions that may be considered in determining the range of values
of our investments include the nature and realizable value of any collateral,
the portfolio company's ability to make payments, market yield trend analysis
and volatility in future interest rates, call and put features, the markets in
which the portfolio company does business, comparison to publicly traded
companies, discounted cash flows and other relevant factors.



We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

? Each investment is initially valued by the responsible investment professionals

of Saratoga Investment Advisors and preliminary valuation conclusions are

documented and discussed with our senior management; and

? An independent valuation firm engaged by our board of directors independently

reviews a selection of these preliminary valuations each quarter so that the

valuation of each investment for which market quotes are not readily available

is reviewed by the independent valuation firm at least once each fiscal year.

We use a third-party independent valuation firm to value our investment in the

subordinated notes of Saratoga CLO and the Class F-R-3 Notes tranche of the


   Saratoga CLO every quarter.



In addition, all our investments are subject to the following valuation process:

? The audit committee of our board of directors reviews and approves each

preliminary valuation and Saratoga Investment Advisors and an independent

valuation firm (if applicable) will supplement the preliminary valuation to

reflect any comments provided by the audit committee; and

? Our board of directors discusses the valuations and approves the fair value of

each investment, in good faith, based on the input of Saratoga Investment

Advisors, independent valuation firm (to the extent applicable) and the audit


   committee of our board of directors.




Our investment in Saratoga CLO is carried at fair value, which is based on a
discounted cash flows that utilizes prepayment, re-investment and loss
assumptions based on historical experience and projected performance, economic
factors, the characteristics of the underlying cash flow, and market comparables
for equity interests in collateralized loan obligation funds similar to Saratoga
CLO, when available, as determined by Saratoga Investment Advisors and
recommended to our board of directors. Specifically, we use Intex cash flows, or
an appropriate substitute, to form the basis for the valuation of our investment
in Saratoga CLO. The cash flows use a set of inputs including projected default
rates, recovery rates, reinvestment rate and prepayment rates in order to arrive
at estimated valuations. The inputs are based on available market data and
projections provided by third parties as well as management estimates. We use
the output from the Intex models (i.e., the estimated cash flows) to perform a
discounted cash flow analysis on expected future cash flows to determine a
valuation for our investment in Saratoga CLO.



Revenue Recognition



Income Recognition



Interest income, adjusted for amortization of premium and accretion of discount,
is recorded on an accrual basis to the extent that such amounts are expected to
be collected. The Company stops accruing interest on its investments when it is
determined that interest is no longer collectible. Discounts and premiums on
investments purchased are accreted/amortized over the life of the respective
investment using the effective yield method. The amortized cost of investments
represents the original cost adjusted for the accretion of discounts and
amortization of premiums on investments.



                                       81





Loans are generally placed on non-accrual status when there is reasonable doubt
that principal or interest will be collected. Accrued interest is generally
reserved when a loan is placed on non-accrual status. Interest payments received
on non-accrual loans may be recognized as a reduction in principal depending
upon management's judgment regarding collectability. Non-accrual loans are
restored to accrual status when past due principal and interest is paid and, in
management's judgment, are likely to remain current, although we may make
exceptions to this general rule if the loan has sufficient collateral value and
is in the process of collection.



Payment-in-Kind Interest



The Company holds debt and preferred equity investments in its portfolio that
contain a payment-in-kind ("PIK") interest provision. The PIK interest, which
represents contractually deferred interest added to the investment balance that
is generally due at maturity, is generally recorded on the accrual basis to the
extent such amounts are expected to be collected. We stop accruing PIK interest
if we do not expect the issuer to be able to pay all principal and interest

when
due.



Revenues



We generate revenue in the form of interest income and capital gains on the debt
investments that we hold and capital gains, if any, on equity interests that we
may acquire. We expect our debt investments, whether in the form of leveraged
loans or mezzanine debt, to have terms of up to ten years, and to bear interest
at either a fixed or floating rate. Interest on debt will be payable generally
either quarterly or semi-annually. In some cases, our debt or preferred equity
investments may provide for a portion or all of the interest to be PIK. To the
extent interest is PIK, it will be payable through the increase of the principal
amount of the obligation by the amount of interest due on the then-outstanding
aggregate principal amount of such obligation. The principal amount of the debt
and any accrued but unpaid interest will generally become due at the maturity
date. In addition, we may generate revenue in the form of commitment,
origination, structuring or diligence fees, fees for providing managerial
assistance or investment management services and possibly consulting fees. Any
such fees will be generated in connection with our investments and recognized as
earned. We may also invest in preferred equity or common equity securities that
pay dividends on a current basis.



On January 22, 2008, we entered into a collateral management agreement with
Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga
CLO was initially refinanced in October 2013 with its reinvestment period
extended to October 2016. On November 15, 2016, we completed a second
refinancing of the Saratoga CLO with its reinvestment period extended to October
2018.



On August 7, 2018, we entered into an unsecured loan agreement, CLO 2013-1
Warehouse Loan, with Saratoga Investment Corp. CLO 2013-1 Warehouse, Ltd, a
wholly-owned subsidiary of Saratoga CLO, pursuant to which CLO 2013-1 Warehouse
may borrow from time to time up to $20 million from us in order to provide
capital necessary to support warehouse activities. The CLO 2013-1 Warehouse
Loan, which expires on February 7, 2020, bears interest at an annual rate of 3M
USD LIBOR + 7.5%. During the year ended February 28, 2019, the maximum amount
invested by us in the CLO 2013-1 Warehouse Loan amounted to $20.0 million.



On December 14, 2018, we completed a third refinancing and upsize of the
Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended
its reinvestment period to January 2021, and extended its legal maturity date to
January 2030. A non-call period of January 2020 was also added. Following this
refinancing, the Saratoga CLO portfolio increased from approximately $300.0
million in aggregate principal amount to approximately $500.0 million of
predominantly senior secured first lien term loans. In addition to refinancing
its liabilities, we invested an additional $13.8 million in all of the newly
issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in
aggregate principal amount of the Class F-R-2 and $7.5 million aggregate
principal amount of the Class G-R-2 notes tranches at par, with a coupon of
LIBOR plus 8.75% and LIBOR plus 10.00%, respectively. As part of this
refinancing, we also redeemed our existing $4.5 million aggregate amount of the
Class F notes tranche at par and the $20.0 million CLO 2013-1 Warehouse Loan was
repaid.



On February 11, 2020, we entered into an unsecured loan agreement ("CLO 2013-1
Warehouse 2 Loan") with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd
("CLO 2013-1 Warehouse 2"), a wholly-owned subsidiary of Saratoga CLO, pursuant
to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million
from the Company in order to provide capital necessary to support warehouse
activities. On October 23, 2020, the CLO 2013-1 Warehouse 2 Loan was increased
to $25.0 million availability, which was immediately fully drawn and, which
expires on August 20, 2021. The interest rate was also amended to be based on a
pricing grid, starting at an annual rate of 3M USD LIBOR + 4.46%. During the
fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd was

repaid in full.



                                       82





On February 26, 2021, the Company completed the fourth refinancing of the
Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO
reinvestment period to April 2024, and extended its legal maturity to April
2033. A non-call period ending February 2022 was also added. In addition, and as
part of the refinancing, the Saratoga CLO has also been upsized from
$500 million in assets to approximately $650 million. As part of this
refinancing and upsizing, the Company invested an additional $14.0 million in
all of the newly issued subordinated notes of the Saratoga CLO, and purchased
$17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at
par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million
of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid.
The Company also paid $2.6 million of transaction costs related to the
refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from
future equity distributions. As of February 28, 2021, there remained an
outstanding receivable of $2.6 million for such transaction costs which is
presented as due from affiliate on the Company's consolidated statement of
assets and liabilities.



The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO's assets, paid quarterly to the extent of available proceeds. Prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO's assets, paid quarterly to the extent of available proceeds.





Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes
on December 14, 2018, we are no longer entitled to an incentive management fee
equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated
notes receive an internal rate of return paid in cash equal to or greater than
12.0%.



Interest income on our investment in Saratoga CLO is recorded using the
effective interest method in accordance with the provisions of ASC Topic 325-40,
Investments-Other, Beneficial Interests in Securitized Financial Assets ("ASC
325-40"), based on the anticipated yield and the estimated cash flows over the
projected life of the investment. Yields are revised when there are changes in
actual or estimated cash flows due to changes in prepayments and/or
re-investments, credit losses or asset pricing. Changes in estimated yield are
recognized as an adjustment to the estimated yield over the remaining life of
the investment from the date the estimated yield was changed.



ASC 606



In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers
("ASC 606"), which supersedes the revenue recognition requirements in Revenue
Recognition (ASC 605). Under the new guidance, an entity should recognize
revenue to depict the transfer of promised goods or services to customers in an
amount that reflects the consideration to which the entity expects to be
entitled in exchange for those goods or services. In May 2016, ASU 2016-12
amended ASU 2014-09 and deferred the effective period for annual periods
beginning after December 15, 2017. Management has concluded that the majority of
its revenues associated with financial instruments are scoped out of ASC 606,
and has concluded that the only significant impact relates to the timing of the
recognition of the CLO incentive fee income. We adopted ASC 606 under the
modified retrospective approach using the practical expedient provided for,
therefore the presentation of prior periods has not been adjusted.



Expenses



Our primary operating expenses include the payment of investment advisory and
management fees, professional fees, directors and officers insurance, fees paid
to independent directors and administrator expenses, including our allocable
portion of our administrator's overhead. Our investment advisory and management
fees compensate our Manager for its work in identifying, evaluating,
negotiating, closing and monitoring our investments. We bear all other costs and
expenses of our operations and transactions, including those relating to:



 ? organization;



? calculating our net asset value (including the cost and expenses of any

independent valuation firm);

? expenses incurred by our Manager payable to third parties, including agents,

consultants or other advisers, in monitoring our financial and legal affairs

and in monitoring our investments and performing due diligence on our

prospective portfolio companies;






                                       83




? expenses incurred by our Manager payable for travel and due diligence on our

prospective portfolio companies;


 ? interest payable on debt, if any, incurred to finance our investments;

? offerings of our common stock and other securities;

? investment advisory and management fees;

? fees payable to third parties, including agents, consultants or other advisers,

relating to, or associated with, evaluating and making investments;

? transfer agent and custodial fees;

? federal and state registration fees;

? all costs of registration and listing our common stock on any securities


   exchange;



? federal, state and local taxes;

? independent directors' fees and expenses;

? costs of preparing and filing reports or other documents required by

governmental bodies (including the U.S. Securities and Exchange Commission


   ("SEC") and the SBA);




? costs of any reports, proxy statements or other notices to common stockholders


   including printing costs;




? our fidelity bond, directors and officers errors and omissions liability

insurance, and any other insurance premiums;

? direct costs and expenses of administration, including printing, mailing, long

distance telephone, copying, secretarial and other staff, independent auditors

and outside legal costs; and

? administration fees and all other expenses incurred by us or, if applicable,

the administrator in connection with administering our business (including

payments under the Administration Agreement based upon our allocable portion of

the administrator's overhead in performing its obligations under an

Administration Agreement, including rent and the allocable portion of the cost

of our officers and their respective staffs (including travel expenses)).






Pursuant to the investment advisory and management agreement that we had with
GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed
to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of
1.75% of the average value of our total assets (other than cash or cash
equivalents but including assets purchased with borrowed funds) at the end of
the two most recently completed fiscal quarters and an incentive fee.



The incentive fee had two parts:

? A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee

net investment income, expressed as a rate of return on the value of the net

assets at the end of the immediately preceding quarter, that exceeded a 1.875%

quarterly hurdle rate measured as of the end of each fiscal quarter. Under this

provision, in any fiscal quarter, our investment adviser received no incentive

fee unless our pre-incentive fee net investment income exceeded the hurdle rate

of 1.875%. Amounts received as a return of capital were not included in

calculating this portion of the incentive fee. Since the hurdle rate was based

on net assets, a return of less than the hurdle rate on total assets could

still have resulted in an incentive fee.

? A fee, payable at the end of each fiscal year, equal to 20.0% of our net

realized capital gains, if any, computed net of all realized capital losses and

unrealized capital depreciation, in each case on a cumulative basis on each

investment in the Company's portfolio, less the aggregate amount of capital


   gains incentive fees paid to the investment adviser through such date.




                                       84





We deferred cash payment of any incentive fee otherwise earned by our former
investment adviser if, during the then most recent four full fiscal quarters
ending on or prior to the date such payment was to be made, the sum of (a) our
aggregate distributions to our stockholders and (b) our change in net assets
(defined as total assets less liabilities) (before taking into account any
incentive fees payable during that period) was less than 7.5% of our net assets
at the beginning of such period. These calculations were appropriately pro-rated
for the first three fiscal quarters of operation and adjusted for any share
issuances or repurchases during the applicable period. Such incentive fee would
become payable on the next date on which such test had been satisfied for the
most recent four full fiscal quarters or upon certain terminations of the
investment advisory and management agreement. We commenced deferring cash
payment of incentive fees during the quarterly period ended August 31, 2007 and
continued to defer such payments through the quarterly period ended May 31,
2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our
investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in
fees for services previously provided to us; of which $0.3 million has been paid
by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6
million in connection with the consummation of the stock purchase transaction
with Saratoga Investment Advisors and certain of its affiliates described
elsewhere in this Annual Report.



The terms of the investment advisory and management agreement with Saratoga
Investment Advisors, our current investment adviser, are substantially similar
to the terms of the investment advisory and management agreement we had entered
into with GSCP (NJ), L.P., our former investment adviser, except for the
following material distinctions in the fee terms:



? The capital gains portion of the incentive fee was reset with respect to gains

and losses from May 31, 2010, and therefore losses and gains incurred prior to

such time will not be taken into account when calculating the capital gains fee

payable to Saratoga Investment Advisors and, as a result, Saratoga Investment

Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010.

In addition, the cost basis for computing realized gains and losses on

investments held by us as of May 31, 2010 equal the fair value of such

investment as of such date. Under the investment advisory and management

agreement with our former investment adviser, GSCP (NJ), L.P., the capital

gains fee was calculated from March 21, 2007, and the gains were substantially


   outweighed by losses.




? Under the "catch up" provision, 100.0% of our pre-incentive fee net investment

income with respect to that portion of such pre-incentive fee net investment

income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal

quarter is payable to Saratoga Investment Advisors. This will enable Saratoga

Investment Advisors to receive 20.0% of all net investment income as such

amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will

receive 20.0% of any additional net investment income. Under the investment

advisory and management agreement with our former investment adviser, GSCP

(NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

? We will no longer have deferral rights regarding incentive fees in the event

that the distributions to stockholders and change in net assets is less than


   7.5% for the preceding four fiscal quarters.




Capital Gains Incentive Fee



The Company records an expense accrual relating to the capital gains incentive
fee payable by the Company to its Manager when the unrealized gains on its
investments exceed all realized capital losses on its investments given the fact
that a capital gains incentive fee would be owed to the Manager if the Company
were to liquidate its investment portfolio at such time. The actual incentive
fee payable to the Company's Manager related to capital gains will be determined
and payable in arrears at the end of each fiscal year and will include only
realized capital gains for the period.



New Accounting Pronouncements





In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform ("ASU
2020-04"). The amendments in ASU 2020-04 provide optional expedients and
exceptions for applying GAAP to contracts, hedging relationships, and other
transactions affected by reference rate reform if certain criteria are met. The
standard is effective as of March 12, 2020 through December 31, 2022. Management
does not believe this optional guidance has a material impact on the Company's
consolidated financial statements and disclosures.



                                       85




SEC Disclosure Update and Simplification





In March 2019, the SEC adopted the final rule under SEC Release No.
33-10618, Fast Act Modernization and Simplification of Regulation S-K, amending
certain disclosure requirements. The amendments are intended to simplify certain
disclosure requirements and to provide for a consistent set of rules to govern
incorporating information by reference and hyperlinking, improve readability and
navigability of disclosure documents, and discourage repetition and disclosure
of immaterial information. The Company has adopted the final rule, as applicable
under SEC Release No. 33-10618 and determined the effect of the adoption of the
simplification rules on financial statements will be limited to the modification
and removal of certain disclosures.



SEC Rule 12b-2 Update



In March 2020, the SEC adopted a final rule under SEC Release No. 34-88365 (the
"Final Rule"), amending the accelerated filer and large accelerated filer
definitions in Exchange Act Rule 12b-2. The amendments include a provision under
which a BDC will be excluded from the "accelerated filer" and "large accelerated
filer" definitions if the BDC has (1) a public float of $75 million or more, but
less than $700 million, and (2) has annual investment income of less than $100
million. In addition, BDCs are subject to the same transition provisions for
accelerated filer and large accelerated filer status as other issuers, but
instead substituting investment income for revenue. The amendments will reduce
the number of issuers required to comply with the auditor attestation on the
internal control over financial reporting requirement provided under Section
404(b) of the Sarbanes-Oxley Act of 2002. The Final Rule applies to annual
report filings due on or after April 27, 2020. The Company has assessed the
Final Rule, and concluded that effective February 28, 2021, it is no longer an
accelerated filer. As a result, the Company has filed this Annual Report on Form
10-K for the fiscal year ending February 28, 2021 as a non-accelerated filer.



Portfolio and investment activity





                                       Investment Portfolio Overview

                                                     February 28,       February 29,       February 28,
                                                         2021               2020               2019
                                                                       ($ in millions)
Number of investments(1)                                        81                 74                 58
Number of portfolio companies(2)                                40                 35                 31
Average investment per portfolio company(2)          $        12.6      $  

     12.9      $        11.8
Average investment size(1)                           $         6.5      $         6.3      $         6.5
Weighted average maturity(3)                               3.2 yrs            3.1 yrs            3.6 yrs
Number of industries                                            31                 28                 24
Non-performing or delinquent investments (fair
value)                                               $         2.1      $         2.1      $         5.7
Fixed rate debt (% of interest earning
portfolio)(3)                                        $    23.3(4.8 %)   $    29.7(6.8 %)   $   55.7(16.3 %)
Fixed rate debt (weighted average current
coupon)(3)                                                     9.8 %              9.3 %             10.4 %
Floating rate debt (% of interest earning
portfolio)(3)                                        $  462.6(95.2 %)   $  404.4(93.2 %)   $  285.0(83.7 %)
Floating rate debt (weighted average current
spread over LIBOR)(3)(4)                                       7.4 %       

      8.0 %              8.6 %





(1) Excludes our investment in the subordinated notes of Saratoga CLO. (2) At February 28, 2021, excludes our investment in the subordinated notes of

Saratoga CLO, Class F-R-3 Notes tranches of Saratoga CLO. At February 29,

2020, excludes our investment in the subordinated notes of Saratoga CLO,

Class F-R-2 Notes and Class G-R-2 Notes tranches of Saratoga CLO and loan to

Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. At February 28, 2019,

excludes our investment in the subordinated notes of Saratoga CLO, Class

F-R-2 Notes and Class G-R-2 Notes tranches of Saratoga CLO. (3) Excludes our investment in the subordinated notes of Saratoga CLO and equity

interests.

(4) Calculation uses either 1-month or 3-month LIBOR, depending on the


    contractual terms, and after factoring in any existing LIBOR floors.




During the fiscal year ended February 28, 2021, we invested $202.3 million in
new or existing portfolio companies and had $130.3 million in aggregate amount
of exits and repayments resulting in net investments of $72.0 million for the
year.



                                       86





During the fiscal year ended February 29, 2020, we invested $204.6 million in
new or existing portfolio companies and had $167.3 million in aggregate amount
of exits and repayments resulting in net investments of $37.3 million for the
year.



During the fiscal year ended February 28, 2019, we invested $187.7 million in
new or existing portfolio companies and had $135.7 million in aggregate amount
of exits and repayments resulting in net investments of $52.0 million for the
year.



                             Portfolio Composition


Our portfolio composition at February 28, 2021, February 29, 2020 and February 28, 2019 at fair value was as follows:





                               February 28, 2021                 February 29, 2020                 February 28, 2019
                                             Weighted                          Weighted                          Weighted
                          Percentage         Average        Percentage         Average        Percentage         Average
                           of Total          Current         of Total          Current         of Total          Current
                           Portfolio          Yield          Portfolio          Yield          Portfolio          Yield

Syndicated loans                     - %             - %               - %             - %               - %             - %
First lien term loans             79.5             9.5              71.3             9.6              50.5            10.9
Second lien term loans             4.4            12.3              15.1            10.7              31.3            11.7
Unsecured term loans               0.4               -               0.9             9.3               0.5               -
Structured finance
securities                         9.0            11.6               6.7            11.4               8.8            14.6
Equity interests                   6.7               -               6.0               -               8.9             3.1
Total                            100.0 %           9.1 %           100.0 %           9.3 %           100.0 %          10.7 %




At February 28, 2021, our investment in the subordinated notes of Saratoga CLO,
a collateralized loan obligation fund, had a fair value of $31.4 million and
constituted 5.7% of our portfolio. This investment constitutes a first loss
position in a portfolio that, as of February 28, 2021 and February 29, 2020, was
composed of $603.7 million and $528.4 million, respectively, in aggregate
principal amount of primarily senior secured first lien term loans. In addition,
as of February 28, 2021, we also own $17.9 million in aggregate principal of the
F-R-3 Notes in the Saratoga CLO, that only rank senior to the subordinated
notes.



This investment is subject to unique risks. (See "Part 1. Item 1A. Risk
Factors-Our investment in Saratoga CLO constitutes a leveraged investment in a
portfolio of predominantly senior secured first lien term loans and is subject
to additional risks and volatility"). We do not consolidate the Saratoga CLO
portfolio in our consolidated financial statements. Accordingly, the metrics
below do not include the underlying Saratoga CLO portfolio investments. However,
at February 28, 2021, $584.6 million or 98.7% of the Saratoga CLO portfolio
investments in terms of market value had a CMR (as defined below) color rating
of green or yellow and four Saratoga CLO portfolio investments were in default
with a fair value of $0.8 million. At February 29, 2020, $494.2 million or 98.6%
of the Saratoga CLO portfolio investments in terms of market value had a CMR (as
defined below) color rating of green or yellow and two Saratoga CLO portfolio
investment were in default with a fair value of $1.4 million. For more
information relating to Saratoga CLO, see the audited financial statements for
Saratoga CLO included elsewhere herein.



Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system ("CMR"). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)-performing credit; (Yellow)-underperforming credit; (Red)-in principal payment default and/or expected loss of principal.





                                       87





                           Portfolio CMR distribution


The CMR distribution of our investments at February 28, 2021 and February 29, 2020 was as follows:

Saratoga Investment Corp.





                      February 28, 2021                     February 29, 2020
                                    Percentage                            Percentage
               Investments at        of Total        Investments at        of Total
Color Score      Fair Value         Portfolio          Fair Value         Portfolio
                                         ($ in thousands)
Green         $        453,297             81.8 %   $        429,784             88.5 %
Yellow                  32,559              5.9                2,141              0.5
Red                          -              0.0                2,137              0.4
N/A(1)                  68,457             12.3               51,570             10.6
Total         $        554,313            100.0 %   $        485,632            100.0 %





(1) Comprised of our investment in the subordinated notes of Saratoga CLO and


     equity interests.




The change in reserve from $1.2 million as of February 29, 2020 to $1.2 million
as of February 28, 2021 primarily related to the increase in reserve for the
year for our investments in My Alarm Center, LLC and Taco Mac, offset by the
reversal of the full reserve for our investment in Roscoe Medical Inc.

The CMR distribution of Saratoga CLO investments at February 28, 2021 and February 29, 2020 was as follows:





Saratoga CLO



                      February 28, 2021                     February 29, 2020
                                    Percentage                            Percentage
               Investments at        of Total        Investments at        of Total
Color Score      Fair Value         Portfolio          Fair Value         Portfolio
                                         ($ in thousands)
Green         $        514,183             86.8 %   $        456,767             91.1 %
Yellow                  70,415             11.9               37,446              7.5
Red                      6,921              1.2                6,787              1.4
N/A(1)                     501              0.1                    0              0.0
Total         $        592,020            100.0 %   $        501,000            100.0 %





(1) Comprised of Saratoga CLO's equity interests.






                                       88





            Portfolio composition by industry grouping at fair value


The following table shows our portfolio composition by industry grouping at fair value at February 28, 2021 and February 29, 2020:

Saratoga Investment Corp.



                                                    February 28, 2021                      February 29, 2020*
                                                                   Percentage                             Percentage
                                             Investments At         of Total        Investments At         of Total
                                               Fair Value          Portfolio          Fair Value          Portfolio
                                                                        ($ in thousands)
Education Software                         $           88,090             15.9 %   $          96,055             19.8 %
IT Services                                            73,087             13.2                62,541             12.9
Structured Finance Securities(1)                       49,779             

9.0                34,675              7.1
Healthcare Services                                    42,410              7.7                28,455              5.9
Education Services                                     40,384              7.1                36,365              7.5
Healthcare Software                                    28,972              5.2                30,764              6.3
Sports Management                                      25,469              4.6                25,740              5.3
Dental Practice Management Software                    23,659             

4.3                     -              0.0
Payroll Services                                       18,333              3.3                19,055              3.9
Real Estate Services                                   18,032              3.3                     -              0.0
Marketing Services                                     17,372              3.1                14,200              2.9
Hospitality/Hotel                                      17,080              3.1                14,894              3.1
HVAC Services and Sales                                14,894              2.7                     -              0.0
Property Management                                    14,578              2.6                11,503              2.4
Corporate Governance                                   13,265              2.4                 9,090              1.9
Cyber Security                                         13,174              2.4                 9,982              2.1
Industrial Products                                     9,047              1.6                10,779              2.2
Waste Services                                          9,000              1.6                 9,000              1.9
Dental Practice Management                              7,133              1.3                     -              0.0
Facilities Maintenance                                  6,193              1.1                 5,375              1.1
Non-profit Services                                     5,554              1.0                 5,555              1.1
Healthcare Supply                                       5,422              1.0                 2,137              0.4
Field Service Management                                4,018              0.7                 2,970              0.6
Office Supplies                                         3,610              0.7                 3,799              0.8
Restaurant                                              2,141              0.4                 2,140              0.4
Corporate Education Software                            1,050              0.2                     -              0.0
Staffing Services                                         925              0.2                   922              0.2

Healthcare Products Manufacturing                         567             

0.1                 7,717              1.6
Consumer Products                                         475              0.1                   418              0.1
Financial Services                                        419              0.1                32,090              6.6
Consumer Services                                         181              0.0                 1,997              0.4
Metals                                                      -              0.0                 3,130              0.6

Construction Management Services                            -             

0.0                 4,284              0.9
Total                                      $          554,313            100.0 %   $         485,632            100.0 %





* Certain reclassifications have been made to previously reported industry

groupings to show results on a consistent basis across periods.

(1) As of February 28, 2021, comprised of our investment in the subordinated

notes and Class F-R-3 Notes of Saratoga CLO. As of February 29, 2020,

comprised of our investment in the subordinated notes, Class F-R-2 Notes and


     Class G-R-2 Notes of Saratoga CLO and Saratoga Investment Corp. CLO 2013-1
     Warehouse 2, Ltd.




                                       89




The following table shows Saratoga CLO's portfolio composition by industry grouping at fair value at February 28, 2021 and February 29, 2020:





Saratoga CLO



                                                   February 28, 2021                   February 29, 2020
                                             Investments        Percentage       Investments        Percentage
                                                  at             of Total             at             of Total
                                              Fair Value        Portfolio         Fair Value        Portfolio
                                                                     ($ in

thousands)


Banking, Finance, Insurance & Real Estate   $      105,326             17.9

%   $       87,957             17.6 %
Services: Business                                  55,588              9.4             45,735              9.1
High Tech Industries                                50,106              8.5             32,897              6.6

Healthcare & Pharmaceuticals                        46,689              7.9

            39,978              8.0
Services: Consumer                                  31,604              5.4             28,327              5.6
Telecommunications                                  29,878              5.1             28,317              5.6
Aerospace & Defense                                 25,952              4.4             25,093              5.0

Chemicals, Plastics, & Rubber                       23,302              3.9             14,689              2.9
Hotel, Gaming & Leisure                             20,515              3.4             16,883              3.4
Media: Advertising, Printing & Publishing           19,826              3.3             19,808              4.0
Consumer goods: Non-durable                         19,343              3.3             15,700              3.1
Automotive                                          19,159              3.2             13,820              2.8
Containers, Packaging & Glass                       18,822              3.2

            15,753              3.1
Beverage, Food & Tobacco                            17,998              3.1             21,637              4.3
Consumer goods: Durable                             13,143              2.2             11,674              2.3
Retail                                              12,880              2.2             14,538              2.9
Capital Equipment                                    9,961              1.7              9,551              1.9

Media: Broadcasting & Subscription                   9,426              1.6

             7,959              1.6
Utilities: Oil & Gas                                 8,235              1.4              7,306              1.5
Forest Products & Paper                              6,954              1.2              5,385              1.1
Transportation: Consumer                             6,183              1.0              1,914              0.4
Metals & Mining                                      6,127              1.0              4,112              0.8

Media: Diversified & Production                      6,035              1.0

             2,711              0.5
Wholesale                                            5,841              1.0              1,928              0.4
Transportation: Cargo                                5,812              1.0              7,054              1.4
Construction & Building                              5,362              0.9              7,617              1.5
Energy: Electricity                                  4,547              0.8              3,357              0.7
Utilities: Electric                                  4,209              0.7              4,752              1.0
Energy: Oil & Gas                                    2,208              0.4              3,559              0.7
Environmental Industries                               989              0.2                989              0.2

Total                                       $      592,020            100.3 %   $      501,000            100.0 %




                                       90





           Portfolio composition by geographic location at fair value



The following table shows our portfolio composition by geographic location at
fair value at February 28, 2021 and February 29, 2020. The geographic
composition is determined by the location of the corporate headquarters of the
portfolio company.



                       February 28, 2021                     February 29, 2020
                                     Percentage                            Percentage
                Investments at        of Total        Investments at        of Total
                  Fair Value         Portfolio          Fair Value         Portfolio
                                          ($ in thousands)
Southeast      $        167,397             30.2 %   $        165,353             34.0 %
West                    145,907             26.3               99,390             20.5
Midwest                 110,125             19.9               75,528             15.5
Southwest                39,334              7.1               61,456             12.7
Northwest                13,174              2.4                9,981              2.1
Northeast                 7,314              1.3               18,047              3.7
Other(1)                 71,062             12.8               55,877             11.5
Total          $        554,313            100.0 %   $        485,632            100.0 %





(1) As of February 28, 2021, comprised of our investments in the subordinated

notes, F-R-3 Notes of Saratoga CLO and foreign investments. As of February

29, 2020, comprised of our investment in the subordinated notes, Class F-R-2


     Notes and Class G-R-2 Notes of Saratoga CLO, Saratoga Investment Corp. CLO
     2013-1 Warehouse 2, Ltd and foreign investments.




                                       91





Results of operations



Operating results for the fiscal years ended February 28, 2021, February 29, 2020 and February 28, 2019 were as follows:





                                                                      For the Year Ended
                                                      February 28,       February 29,       February 28,
                                                          2021               2020               2019
                                                                       ($ in thousands)
Total investment income                              $       57,650     $       58,448     $       47,708
Total operating expenses                                     34,537             43,587             29,406
Net investment income                                        23,113             14,861             18,302

Net realized gains (losses) from investments                 (8,704 )           42,877              4,874
Income tax (provision) benefit from realized gain
on investments                                               (3,895 )
Net change in unrealized appreciation
(depreciation) on investments                                 4,966               (771 )           (2,900 )
Net change in provision for deferred taxes on
unrealized (appreciation) depreciation on
investments                                                    (574 )              355             (1,767 )
Loss on extinguishment of debt*                                (129 )           (1,583 )                -
Net increase in net assets resulting from
operations                                           $       14,777     $       55,739     $       18,509

* Certain prior period amounts have been reclassified to conform to current


   period presentation.




Investment income



The composition of our investment income for the fiscal years ended February 28, 2021, February 29, 2020 and February 28, 2019 were as follows:





                                                                 For the Year Ended
                                                      February        February        February
                                                      28, 2021        29, 2020        28, 2019
                                                                  ($ in thousands)
Interest from investments                            $    51,714     $    48,047     $    43,297

Interest from cash and cash equivalents                       14           

 536              65
Management fee income                                      2,508           2,504           1,722
Incentive fee income                                           -               -             633

Structuring and advisory fee income                        2,157          

5,286           1,355
Other income                                               1,257           2,075             636
Total investment income                              $    57,650     $    58,448     $    47,708




For the fiscal year ended February 28, 2021, total investment income decreased
$0.8 million, or 1.4% compared to the fiscal year ended February 29, 2020.
Interest income from investments increased $3.7 million, or 7.6%, to $51.7
million for the year ended February 28, 2021 from $48.0 million for the fiscal
year ended February 29, 2020. This reflects an increase of 14.1% in total
investments to $554.3 million at February 28, 2021 from $485.6 million at
February 29, 2020, offset by the reduction in LIBOR during this same period. At
February 28, 2021, the weighted average current yield on investments was 9.1%
compared to 9.3% at February 29, 2020, which offset some of the interest income
increase.



For the fiscal year ended February 29, 2020, total investment income increased
$10.7 million, or 22.5% compared to the fiscal year ended February 28, 2019.
Interest income from investments increased $4.7 million, or 11.0%, to $48.0
million for the year ended February 29, 2020 from $43.3 million for the fiscal
year ended February 28, 2019. This reflects an increase of 20.8% in total
investments to $485.6 million at February 29, 2020 from $402.0 million at
February 28, 2019. At February 29, 2020, the weighted average current yield on
investments was 9.3% compared to 10.7% at February 28, 2019, which offset some
of the interest income increase.



For the fiscal year ended February 28, 2021 and February 29, 2020, total PIK
income was $2.6 million and $4.5 million, respectively. This decrease was
primarily due to our sale in Easy Ice, LLC, which primarily generated PIK
interest income. The Company sold its interest in Easy Ice, LLC during the end
of the year ended February 29, 2020.



                                       92





For the fiscal year ended February 29, 2020 and February 28, 2019, total PIK
income was $4.5 million and $4.2 million, respectively. This increase was
primarily due to the increase in investment in Easy Ice, LLC, which primarily
generated PIK interest income. The Company sold its interest in Easy Ice, LLC
during the year ended February 29, 2020.



Following the third refinancing of the CLO on December 14, 2018, the Company is
no longer entitled to receive the incentive fee. For the years ended February
28, 2019 incentive fee income of $0.6 million, was recognized related to the
Saratoga CLO, reflecting the 12.0% hurdle rate that has been achieved.



For the fiscal year ended February 28, 2021, February 29, 2020 and February 28,
2019, total structuring and advisory fee income was $2.2 million, $5.3 million
and $1.4 million, respectively. Structuring and advisory fee income represents
fee income earned and received performing certain investment and advisory
activities during the closing of new investments.



For the fiscal year ended February 28, 2021, February 29, 2020 and February 28,
2019, other income was $1.3 million, $2.1 million and $0.6 million,
respectively. Other income includes dividends received, origination fees and
prepayment income fees and is recorded in the consolidated statements of
operations when earned.



Operating expenses


The composition of our operating expenses for the years ended February 28, 2021, February 29, 2020 and February 28, 2019 were as follows:





                                                                      For the Year Ended
                                                      February 28,       February 29,       February 28,
                                                          2021               2020               2019
                                                                       ($ in thousands)

Interest and debt financing expenses                 $       13,587     $       14,683     $       13,126
Base management fees                                          9,098              8,099              6,879
Incentive management fees                                     4,904        

    14,164              4,891
Professional fees                                             1,706              1,684              1,849
Administrator expenses                                        2,546              2,131              1,896
Insurance                                                       285                260                253

Directors fees and expenses                                     290                278                291
General and administrative and other expenses                 1,428              1,326              1,248
Income tax benefit                                                1                962             (1,027 )
Excise tax expense (credit)                                     692                  -                  -
Total operating expenses                             $       34,537     $  

    43,587     $       29,406




For the year ended February 28, 2021, total operating expenses decreased $9.0
million, or 20.8% compared to the year ended February 29, 2020. For the year
ended February 29, 2020, total operating expenses increased $14.2 million, or
48.2% compared to the year ended February 28, 2019.



For the year ended February 28, 2021, the decrease in interest and debt financing expenses is primarily attributable to a lower blended cost of borrowings, with the higher-yield 2023 Notes being replaced with the lower-cost 2025 Notes and increased lower-cost SBA debentures.





Total average outstanding debt decreased from $273.8 million for the year ended
February 29, 2020 to $264.2 million for the year ended February 28, 2021. For
the year ended February 28, 2021, the weighted average interest rate on our
outstanding indebtedness was 4.46% compared to 4.71% for the year ended February
29, 2020. The decrease in weighted average interest rate and average outstanding
debt was primarily due to the issuance of the lower-cost 2025 Notes and the
repayment of the higher-cost 2023 Notes, and the issuance of new SBA debentures
that carry a lower interest rate. The average outstanding borrowings of the 2023
Notes decreased $63.2 million from $63.2 for the year ended February 29, 2020 to
$0 million for the year ended February 28, 2021. On December 21, 2019 and
February 7, 2020, the Company redeemed $50.0 million and $24.45 million,
respectively, in aggregate principal amounts of $74.45 million in aggregate
principal amounts issued and outstanding 2023 Notes. At February 28, 2021 and
February 29, 2020, the SBA debentures represented 56.2% and 71.4% of overall
debt, respectively.



                                       93





For the years ended February 29, 2020 and February 28, 2019, the increase in
interest and debt financing expenses is primarily attributable to an increase in
total outstanding debt. The increase is primarily attributable to an increase in
average outstanding debt from $249.3 million for the year ended February 28,
2019 to $273.8 million for the year ended February 29, 2020. For the year ended
February 29, 2020, the weighted average interest rate on our outstanding
indebtedness was 4.71% compared to the 4.62% for the year ended February 28,
2019. The increase in weighted average interest rate was primarily driven by the
issuance of the 2025 Notes which carry a fixed rate of 6.25%, versus the SBA
debentures that carry a lower interest rate. At February 29, 2020 and
February 28, 2019, the SBA debentures represented 71.4% and 52.7% of overall
debt, respectively.



For the year ended February 28, 2021, base management fees increased $1.0
million, or 12.3% compared to the fiscal year ended February 29, 2020. The
increase in base management fees results from the 12.3% increase in the average
value of our total assets, less cash and cash equivalents, from $462.8 million
as of February 29, 2020 to $519.9 million as of February 28, 2021.



For the year ended February 29, 2020, base management fees increased $1.2
million, or 17.7% compared to the fiscal year ended February 28, 2019. The
increase in base management fees results from the 17.7% increase in the average
value of our total assets, less cash and cash equivalents, from $393.1 million
as of February 28, 2019 to $462.8 million as of February 29, 2020.



For the year ended February 28, 2021, incentive management fees decreased $9.3
million, or 65.4% compared to the fiscal year ended February 29, 2020. The first
part of the incentive management fees decreased this year from $5.8 million for
the year ended February 29, 2020 to $5.4 million for the year ended February 28,
2021,as higher average net equity during this period resulted in an increase to
the net investment income hurdle rate pursuant to the Management Agreement. The
incentive management fees related to capital gains decreased from $8.4 million
expense for the fiscal year ended February 29, 2020 to $(0.5) million benefit
for the fiscal year ended February 28, 2021, reflecting a reversal of incentive
fee accrual due to an increase in unrealized depreciation on investments during
the year ended February 28, 2021.



For the year ended February 29, 2020, incentive management fees increased $9.3
million, or 189.6% compared to the fiscal year ended February 28, 2019. The
first part of the incentive management fees increased this year from $4.6
million for the year ended February 28, 2019 to $5.8 million for the year ended
February 29, 2020, as higher average total assets of 17.7% has led to increased
net investment income above the hurdle rate pursuant to the investment advisory
and management agreement. The incentive management fees related to capital gains
increased from $0.3 million for the fiscal year ended February 28, 2019 to $8.4
million for the fiscal year ended February 29, 2020, reflecting the net realized
and unrealized gain on investments this year, primarily related to our Censis
Technologies, Inc, and Easy Ice, LLC investments and also including the impact
of the deferred taxes on unrealized appreciation.



For the year ended February 28, 2021, professional fees increased $0.02 million, or 1.3% compared to the fiscal year ended February 29, 2020. This increase primarily relates to increased legal and accounting fees this year, as investment activities continue to grow.





For the year ended February 29, 2020, professional fees decreased $0.2 million,
or 8.9% compared to the fiscal year ended February 28, 2019. This decrease
primarily relates to decreased legal and accounting fees this year, as the shelf
registration statement last year led to higher fees.



For the year ended February 28, 2021, administrator expenses increased $0.4
million, or 19.5% compared to the fiscal year ended February 29, 2020, which
reflects an increase to the cap on the payment or reimbursement of expenses by
the Company from $2.225 million to $2.775 million, effective August 1, 2020.



For the year ended February 29, 2020, administrator expenses increased $0.2
million, or 12.4% compared to the fiscal year ended February 28, 2019, which
reflects an increase to the cap on the payment or reimbursement of expenses by
the Company from $2.0 million to $2.225 million, effective August 1, 2019.



As discussed above, the decrease in interest and debt financing expenses for the
years ended February 28, 2021, versus February 29, 2020, is primarily
attributable to the change in mix in lower-yield borrowings outstanding, while
the increase versus, the year ended February 28, 2019 is primarily attributable
to an increase in the average amount of outstanding debt as compared to the

prior years.



                                       94





For the fiscal years ended February 28, 2021, February 29, 2020 and February 28,
2019, the average borrowings outstanding under the Credit Facility was
approximately $1.8 million, $0.6 million and $3.4 million, respectively, and the
average weighted average interest rate on the outstanding borrowing under the
Credit Facility was 0.17%, 6.66% and 7.10%, respectively.



For the fiscal years ended February 28, 2021, February 29, 2020 and February 28,
2019, the average borrowings outstanding of SBA debentures was $169.3 million,
$150.0 million and $146.0 million, respectively. For the years ended February
28, 2021, February 29, 2020 and February 28, 2019, the weighted average interest
rate on the outstanding borrowings of the SBA debentures was 3.25%, 3.23% and
3.20%, respectively.


During the year ended February 28, 2021 and February 29, 2020, the average dollar amount of our 6.25% fixed-rate 2025 Notes outstanding was $60.0 million and $60.0 million, respectively.

During the year ended February 28, 2021 and February 29, 2020, the average dollar amount of our 7.25% fixed-rate 2025 Notes outstanding was $43.1 million and $0.0 million, respectively.

During the year ended February 28, 2021 and February 29, 2020, the average dollar amount of our 7.75% fixed-rate 2025 Notes outstanding was $5.0 million and $0.0 million, respectively.

During the year ended February 28, 2021 and February 29, 2020, the average dollar amount of our 6.25% fixed-rate 2027 Notes outstanding was $7.0 million and $0.0 million, respectively.





As discussed above, during the fourth quarter of 2020 fiscal year, the Company
redeemed $74.45 million in aggregate principal amount of issued and outstanding
2023 Notes. During the years ended February 28, 2021, February 29, 2020 and
February 28, 2019, the average dollar amount of our 6.75% fixed-rate 2023 Notes
outstanding was $0.0 million, $63.2 million and $74.5 million, respectively.



For the years ended February 28, 2021, February 29, 2020 and February 28, 2019,
we recognized income tax expense (benefit) of $0.0 million, $1.0 million and
$(1.0) million, respectively. This relates to net deferred federal and state
income tax expense (benefit) with respect to operating gains and losses and
income derived from equity investments held in the taxable blockers.



For the year ended February 28, 2021, we accrued excise taxes of $0.7 million on undistributed taxable income as of December 31, 2020.

Net realized gains (losses) on sales of investments


For the fiscal year ended February 28, 2021, the Company had $130.3 million of
sales, repayments, exits or restructurings resulting in $8.7 million of net
realized loss. The most significant realized gains and losses during the year
ended February 28, 2021 were as follows (dollars in thousands):



                      Fiscal year ended February 28, 2021



                                                                                                    Net
                                                                                                 Realized
Issuer                           Asset Type                  Gross Proceeds        Cost         Gain (Loss)
Elyria Foundry Company, L.L.C.   Equity Interests           $            959     $   9,685     $      (8,726 )

The $8.7 million of net realized losses was from the sales of the equity positions in Elyria Foundry Company, L.L.C.


For the fiscal year ended February 29, 2020, the Company had $167.3 million of
sales, repayments, exits or restructurings resulting in $42.9 million of net
realized gains. The most significant realized gains and losses during the year
ended February 29, 2020 were as follows (dollars in thousands)



                                       95





                      Fiscal year ended February 29, 2020



                                                                                   Net
                                                                                Realized
Issuer                      Asset Type         Gross Proceeds        Cost         Gain
Easy Ice, LLC               Equity Interests   $        41,928     $ 10,703     $  31,225

Censis Technologies, Inc.   Equity Interests            12,280          999

       11,281



The $31.2 million and $11.3 million of net realized gains was from the sales of the equity position in Easy Ice, LLC and Censis Technologies, Inc., respectively.


For the fiscal year ended February 28, 2019, the Company had $135.7 million of
sales, repayments, exits or restructurings resulting in $4.9 million of net
realized gains. The most significant realized gains and losses during the year
ended February 28, 2019 were as follows (dollars in thousands):



                      Fiscal year ended February 28, 2019



                                                                         Net
                                                                      Realized
Issuer            Asset Type          Gross Proceeds      Cost       Gain (Loss)
HMN Holdco, LLC   Equity Interests   $            642     $  62     $         580
HMN Holdco, LLC   Equity Interests              4,539       438             4,101




For the year ended February 28, 2019, the $4.7 million of net realized gains on
our investments in HMN Holdco, LLC was due to a refinancing transaction that
included the sale of our equity position.



Net change in unrealized appreciation (depreciation) on investments

For the year ended February 28, 2021, our investments had a net change in unrealized appreciation of $5.0 million versus a net change in unrealized depreciation of $0.8 million for the year ended February 29, 2020. The most significant cumulative changes in unrealized appreciation (depreciation) for the year ended February 28, 2021, were the following (dollars in thousands):





                      Fiscal year ended February 28, 2021



                                                                                                       YTD Change in
                                                                               Total Unrealized         Unrealized
                                                                                 Appreciation          Appreciation

Issuer                 Asset Type               Cost         Fair Value         (Depreciation)        (Depreciation)
ArbiterSports, LLC     First Term Lien Loan      26,801           25,469                   (1,332 )            (1,306 )
C2 Educational         First Term Lien Loan
Systems                                          15,998           13,499                   (2,499 )            (2,517 )
Elyria Foundry         Equity Interests
Company, L.L.C.                                   9,685              730                   (8,955 )             7,745

Knowland Group, LLC Second Lien Term


                       Loan                      15,768           10,788                   (4,980 )            (4,873 )
My Alarm Center, LLC   Equity Interests             712              181                     (531 )             1,816

Netreo Holdings, LLC First Term Lien Loan


                       & Equity Interests         9,632           15,220                    5,588               1,832

Passageways, Inc. First Term Lien Loan


                       & Equity Interests        10,953           13,264                    2,311               1,173

Roscoe Medical, Inc. Second Lien Term


                       Loan & Equity
                       Interests                  5,649            5,422                     (227 )             2,343
Saratoga Investment    Structured Finance
Corp. CLO 2013-1,      Securities
Ltd.                                             33,847           31,450                   (2,397 )            (1,434 )
Village Realty         First Term Lien Loan
Holdings LLC           & Equity Interests        12,394           14,577                    2,183               2,038




                                       96




The $1.3 million net change in unrealized depreciation in our investment in ArbiterSports, LLC was driven by disruptions to its business due to COVID-related shutdowns.

The $2.5 million net change in unrealized depreciation in our investment C2 Education Systems was driven by disruptions to its business due to COVID-related shutdowns.

The $7.7 million net unrealized loss reversal in our investment in Elyria Foundry Company, L.L.C. was due to the realization of this investment, which resulted in a net unrealized appreciation during FY21.

The $4.9 million net change in unrealized depreciation in our investment in Knowland Group, LLC was driven by disruptions to its business due to COVID-related shutdowns.

The $1.8 million net change in unrealized depreciation in our investment in My Alarm Center, LLC was driven by increasing leverage levels combined with declining market conditions in the sector.

The $1.8 million net change in unrealized appreciation in our investment in Netreo Holdings, LLC was driven by growth and improved financial performance.

The $1.2 million net change in unrealized appreciation in our investment in Passageways, Inc. was driven by growth and improved financial performance.

The $2.3 million net change in unrealized appreciation in our investment in Roscoe Medical, Inc. was driven by continued improvement in the company's performance.





The $1.4 million of unrealized depreciation in our investment in Saratoga
Investment Corp. CLO 2013-1, Ltd. was driven by a reduction in base interest
rates during FY 2021, along with expenses resulting from the recapitalization of
the CLO.


The $2.0 million net change in unrealized appreciation in our investment in Village Realty Holdings, LLC was driven by increased customer demand during its peak season this year.

For the year ended February 29, 2020, our investments had a net change in unrealized depreciation of $0.8 million versus a net change in unrealized depreciation of $2.9 million for the year ended February 28, 2019. The most significant cumulative changes in unrealized appreciation (depreciation) for the year ended February 29, 2020, were the following (dollars in thousands):





                      Fiscal year ended February 29, 2020



                                                                                                            YTD Change
                                                                                 Total Unrealized          in Unrealized
                                                                                   Appreciation            Appreciation

Issuer                 Asset Type                  Cost        Fair Value         (Depreciation)          (Depreciation)
Easy Ice, LLC          Second Term Lien Loan &
                       Equity Interests          $      -     $          -     $                   -     $          (3,817 )
GreyHeller LLC         First Term Lien Loan &
                       Equity Interests             7,821            9,981                     2,160                 1,331

Netreo Holdings, LLC First Term Lien Loan &


                       Equity Interests             8,273           12,029                     3,756                 1,655




The $3.8 million net change in unrealized depreciation in our investment in Easy
Ice, LLC was driven by the completion of a sales transaction. In recognizing a
realized gain as a result of the sale, unrealized appreciation was adjusted to
zero, which resulted in a $3.8 million change in unrealized depreciation for the
year.


The $1.3 million net change in unrealized appreciation in our investment GreyHeller LLC was driven by increased operating margins and an increase in overall financial performance.

The $1.7 million net change in unrealized appreciation in our investment in Netreo Holdings, LLC was driven by growth and improved financial performance.





                                       97





For the year ended February 28, 2019, our investments had a net change in
unrealized depreciation of $2.9 million versus a net change in unrealized
appreciation of $10.8 million for the year ended February 28, 2018. The most
significant cumulative net change in unrealized appreciation (depreciation) for
the year ended February 28, 2019, were the following (dollars in thousands):



                                           Fiscal year ended February 28, 2019
                                                                               Total Unrealized         YTD Change in
                                                                                 Appreciation             Unrealized
Issuer                 Asset Type               Cost         Fair Value         (Depreciation)           Appreciation
Elyria Foundry         Equity Interests
Company, L.L.C.                               $   9,685     $      1,804     $             (7,881 )   $           (1,630 )

Roscoe Medical, Inc. Second Lien Term


                       Loan Interests             4,189            2,499                   (1,690 )               (1,419 )
Netreo Holdings, LLC   Equity Interests           3,150            5,179                    2,029                  2,029
My Alarm Center, LLC   Equity Interests           2,358            1,113   

               (1,245 )               (1,274 )



The $1.6 million net change in unrealized depreciation in our investment in Elyria Foundry, L.L.C. was driven by changes in oil and gas end markets since year-end and increased labor costs, negatively impacting the Company's performance.

The $1.4 million net change in unrealized depreciation in our investment in Roscoe Medical, Inc. was driven by decreased operating margins and reduced overall financial performance.

The $2.0 million net change in unrealized appreciation in our investment in Netreo Holdings, LLC was driven by growth and improved financial performance.

The $1.3 million net change in unrealized depreciation in our investment in My Alarm Center, LLC was driven by the issuance of new securities senior to existing investments.

Changes in net assets resulting from operations





For the fiscal years ended February 28, 2021, February 29, 2020 and February 28,
2019, we recorded a net increase in net assets resulting from operations of
$14.8 million, $55.7 million and $18.5 million, respectively. Based on
11,188,629 weighted average common shares outstanding as of February 28, 2021,
our per share net increase in net assets resulting from operations was $1.32 for
the fiscal year ended February 28, 2021. This compares to a per share net
increase in net assets resulting from operations of $5.98 for the fiscal year
ended February 29, 2020 (based on 9,319,192 weighted average common shares
outstanding as of February 29, 2020), and a per share net increase in net assets
resulting from operations of $2.63 for the fiscal year ended February 28, 2019
(based on 7,046,686 weighted average common shares outstanding as of February
28, 2019).


FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES





We intend to continue to generate cash primarily from cash flows from
operations, including interest earned from our investments in debt in middle
market companies, interest earned from the temporary investment of cash in U.S.
government securities and other high-quality debt investments that mature in one
year or less, future borrowings and future offerings of securities.



Although we expect to fund the growth of our investment portfolio through the
net proceeds from future equity offerings, including our dividend reinvestment
plan ("DRIP"), and issuances of senior securities or future borrowings, to the
extent permitted by the 1940 Act, we cannot assure you that our plans to raise
capital will be successful. In this regard, because our common stock has
historically traded at a price below our current net asset value per share and
we are limited in our ability to sell our common stock at a price below net
asset value per share, we have been and may continue to be limited in our
ability to raise equity capital.



In addition, we intend to distribute to our stockholders substantially all of
our operating taxable income in order to satisfy the distribution requirement
applicable to RICs under the Code. In satisfying this distribution requirement,
in accordance with certain applicable provisions of the Code and the Treasury
regulations and a revenue procedure issued by the Internal Revenue Service
("IRS"), a RIC may treat a distribution of its own stock as fulfilling its RIC
distribution requirements if each stockholder may elect to receive his or her
entire distribution in either cash or stock of the RIC subject to a limitation
that the aggregate amount of cash to be distributed to all stockholders must be
at least 20% of the aggregate declared distribution. We may rely on the revenue
procedure in future periods to satisfy our RIC distribution requirement.



                                       98





Also, as a BDC, we generally are required to meet a coverage ratio of total
assets, less liabilities and indebtedness not represented by senior securities,
to total senior securities, which include all of our borrowings and any
outstanding preferred stock, of at least 200.0%, reduced to 150.0% effective
April 16, 2019 following the approval received from the non-interested board of
directors on April 16, 2018. This requirement limits the amount that we may
borrow. Our asset coverage ratio, as defined in the 1940 Act, was 347.1% as of
February 28, 2021 and 607.1% as of February 29, 2020. To fund growth in our
investment portfolio in the future, we anticipate needing to raise additional
capital from various sources, including the equity markets and other
debt-related markets, which may or may not be available on favorable terms,

if
at all.



Consequently, we may not have the funds or the ability to fund new investments,
to make additional investments in our portfolio companies, to fund our unfunded
commitments to portfolio companies, to pay dividends or to repay borrowings.
Also, the illiquidity of our portfolio investments may make it difficult for us
to sell these investments when desired and, if we are required to sell these
investments, we may realize significantly less than their recorded value.



Madison revolving credit facility





Below is a summary of the terms of the senior secured revolving credit facility
we entered into with Madison Capital Funding LLC (the "Credit Facility") on June
30, 2010, which was most recently amended on September 14, 2020.



Availability. The Company can draw up to the lesser of (i) $40.0 million (the
"Facility Amount") and (ii) the product of the applicable advance rate (which
varies from 50.0% to 75.0% depending on the type of loan asset) and the value,
determined in accordance with the Credit Facility (the "Adjusted Borrowing
Value"), of certain "eligible" loan assets pledged as security for the loan (the
"Borrowing Base"), in each case less (a) the amount of any undrawn funding
commitments the Company has under any loan asset and which are not covered by
amounts in the Unfunded Exposure Account referred to below (the "Unfunded
Exposure Amount") and outstanding borrowings. Each loan asset held by the
Company as of the date on which the Credit Facility was closed was valued as of
that date and each loan asset that the Company acquires after such date will be
valued at the lowest of its fair value, its face value (excluding accrued
interest) and the purchase price paid for such loan asset. Adjustments to the
value of a loan asset will be made to reflect, among other things, changes in
its fair value, a default by the obligor on the loan asset, insolvency of the
obligor, acceleration of the loan asset, and certain modifications to the terms
of the loan asset.



The Credit Facility contains limitations on the type of loan assets that are
"eligible" to be included in the Borrowing Base and as to the concentration
level of certain categories of loan assets in the Borrowing Base such as
restrictions on geographic and industry concentrations, asset size and quality,
payment frequency, status and terms, average life, and collateral interests. In
addition, if an asset is to remain an "eligible" loan asset, the Company may not
make changes to the payment, amortization, collateral and certain other terms of
the loan assets without the consent of the administrative agent that will either
result in subordination of the loan asset or be materially adverse to the
lenders.



Collateral. The Credit Facility is secured by substantially all of the assets of
the Company (other than assets held by our SBIC subsidiaries) and includes the
subordinated notes ("CLO Notes") issued by Saratoga CLO and the Company's rights
under the CLO Management Agreement (as defined below).



Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or
through certain lenders at the greater of the prevailing LIBOR rate and 1.00%,
plus an applicable margin of 4.75%. At the Company's option, funds may be
borrowed based on an alternative base rate, which in no event will be less than
2.00%, and the applicable margin over such alternative base rate is 3.75%. In
addition, the Company pays the lenders a commitment fee of 0.75% per year on the
unused amount of the Credit Facility for the duration of the Revolving Period
(defined below). Accrued interest and commitment fees are payable monthly. The
Company was also obligated to pay certain other fees to the lenders in
connection with the closing of the Credit Facility.



Revolving Period and Maturity Date. The Company may make and repay borrowings
under the Credit Facility for a period of three years following the closing of
the Credit Facility (the "Revolving Period"). The Revolving Period may be
terminated at an earlier time by the Company or, upon the occurrence of an event
of default, by action of the lenders or automatically. All borrowings and other
amounts payable under the Credit Facility are due and payable in full five years
after the end of the Revolving Period.



                                       99





Collateral Tests. It is a condition precedent to any borrowing under the Credit
Facility that the principal amount outstanding under the Credit Facility, after
giving effect to the proposed borrowings, not exceed the lesser of the Borrowing
Base or the Facility Amount (the "Borrowing Base Test"). In addition to
satisfying the Borrowing Base Test, the following tests must also be satisfied
(together with Borrowing Base Test, the "Collateral Tests"):



? Interest Coverage Ratio. The ratio (expressed as a percentage) of interest

collections with respect to pledged loan assets, less certain fees and expenses

relating to the Credit Facility, to accrued interest and commitment fees and

any breakage costs payable to the lenders under the Credit Facility for the

last 6 payment periods must equal at least 175.0%.

? Overcollateralization Ratio. The ratio (expressed as a percentage) of the

aggregate Adjusted Borrowing Value of "eligible" pledged loan assets plus the

fair value of certain ineligible pledged loan assets and the CLO Notes (in each

case, subject to certain adjustments) to outstanding borrowings under the

Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

? Weighted Average FMV Test. The aggregate adjusted or weighted value of

"eligible" pledged loan assets as a percentage of the aggregate outstanding

principal balance of "eligible" pledged loan assets must be equal to or greater

than 72.0% and 80.0% during the one-year periods prior to the first and second


   anniversary of the closing date, respectively, and 85.0% at all times
   thereafter.




The Credit Facility also requires payment of outstanding borrowings or
replacement of pledged loan assets upon the Company's breach of its
representation and warranty that pledged loan assets included in the Borrowing
Base are "eligible" loan assets. Such payments or replacements must equal the
lower of the amount by which the Borrowing Base is overstated as a result of
such breach or any deficiency under the Collateral Tests at the time of
repayment or replacement. Compliance with the Collateral Tests is also a
condition to the discretionary sale of pledged loan assets by the Company.



Priority of Payments. During the Revolving Period, the priority of payments
provisions of the Credit Facility require, after payment of specified fees and
expenses and any necessary funding of the Unfunded Exposure Account, that
collections of principal from the loan assets and, to the extent that these are
insufficient, collections of interest from the loan assets, be applied on each
payment date to payment of outstanding borrowings if the Borrowing Base Test,
the Overcollateralization Ratio and the Interest Coverage Ratio would not
otherwise be met. Similarly, following termination of the Revolving Period,
collections of interest are required to be applied, after payment of certain
fees and expenses, to cure any deficiencies in the Borrowing Base Test, the
Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant
payment date.



Reserve Account. The Credit Facility requires the Company to set aside an amount
equal to the sum of accrued interest, commitment fees and administrative agent
fees due and payable on the next succeeding three payment dates (or
corresponding to three payment periods). If for any monthly period during which
fees and other payments accrue, the aggregate Adjusted Borrowing Value of
"eligible" pledged loan assets which do not pay cash interest at least quarterly
exceeds 15.0% of the aggregate Adjusted Borrowing Value of "eligible" pledged
loan assets, the Company is required to set aside such interest and fees due and
payable on the next succeeding six payment dates. Amounts in the reserve account
can be applied solely to the payment of administrative agent fees, commitment
fees, accrued and unpaid interest and any breakage costs payable to the lenders.



Unfunded Exposure Account. With respect to revolver or delayed draw loan assets,
the Company is required to set aside in a designated account (the "Unfunded
Exposure Account") 100.0% of its outstanding and undrawn funding commitments
with respect to such loan assets. The Unfunded Exposure Account is funded at the
time the Company acquires a revolver or delayed draw loan asset and requests a
related borrowing under the Credit Facility. The Unfunded Exposure Account is
funded through a combination of proceeds of the requested borrowing and other
Company funds, and if for any reason such amounts are insufficient, through
application of the priority of payment provisions described above.



Operating Expenses. The priority of payments provision of the Credit Facility
provides for the payment of certain operating expenses of the Company out of
collections on principal and interest during the Revolving Period and out of
collections on interest following the termination of the Revolving Period in
accordance with the priority established in such provision. The operating
expenses payable pursuant to the priority of payment provisions is limited to
$350,000 for each monthly payment date or $2.5 million for the immediately
preceding period of twelve consecutive monthly payment dates. This ceiling can
be increased by the lesser of 5.0% or the percentage increase in the fair market
value of all the Company's assets only on the first monthly payment date to
occur after each one-year anniversary following the closing of the Credit
Facility. Upon the occurrence of a Manager Event (described below), the consent
of the administrative agent is required in order to pay operating expenses
through the priority of payments provision.



                                      100





Events of Default. The Credit Facility contains certain negative covenants,
customary representations and warranties and affirmative covenants and events of
default. The Credit Facility does not contain grace periods for breach by the
Company of certain covenants, including, without limitation, preservation of
existence, negative pledge, change of name or jurisdiction and separate legal
entity status of the Company covenants and certain other customary covenants.
Other events of default under the Credit Facility include, among other things,
the following:


? an Interest Coverage Ratio of less than 150.0%;

? an Overcollateralization Ratio of less than 175.0%;

? the filing of certain ERISA or tax liens;

? the occurrence of certain "Manager Events" such as:

? failure by Saratoga Investment Advisors and its affiliates to maintain

collectively, directly or indirectly, a cash equity investment in the Company

in an amount equal to at least $5.0 million at any time prior to the third

anniversary of the closing date;

? failure of the Management Agreement between Saratoga Investment Advisors and

the Company to be in full force and effect;

? indictment or conviction of Saratoga Investment Advisors or any "key person"

for a felony offense, or any fraud, embezzlement or misappropriation of funds

by Saratoga Investment Advisors or any "key person" and, in the case of "key

persons," without a reputable, experienced individual reasonably satisfactory

to Madison Capital Funding appointed to replace such key person within 30 days;

? resignation, termination, disability or death of a "key person" or failure of

any "key person" to provide active participation in Saratoga Investment

Advisors' daily activities, all without a reputable, experienced individual

reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

? occurrence of any event constituting "cause" under the Collateral Management

Agreement between the Company and Saratoga CLO (the "CLO Management

Agreement"), delivery of a notice under Section 12(c) of the CLO Management

Agreement with respect to the removal of the Company as collateral manager or


   the Company ceases to act as collateral manager under the CLO Management
   Agreement.




Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility
imposes certain additional conditions to the acquisition and pledge of
additional loan assets. Among other things, the Company may not acquire
additional loan assets without the prior written consent of the administrative
agent until such time that the administrative agent indicates in writing its
satisfaction with Saratoga Investment Advisors' policies, personnel and
processes relating to the loan assets.



Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital
Funding LLC for the aggregate amount of all documented, out-of-pocket costs and
expenses, including the reasonable fees and expenses of lawyers, incurred by
Madison Capital Funding LLC in connection with the Credit Facility and the
carrying out of any and all acts contemplated thereunder up to and as of the
date of closing of the stock purchase transaction with Saratoga Investment
Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

? expand the borrowing capacity under the Credit Facility from $40.0 million to

$45.0 million;




? extend the period during which we may make and repay borrowings under the

Credit Facility from July 30, 2013 to February 24, 2015 (the "Revolving

Period"). The Revolving Period may, upon the occurrence of an event of default,

by action of the lenders or automatically, be terminated. All borrowings and

other amounts payable under the Credit Facility are due and payable five years

after the end of the Revolving Period; and

? remove the condition that we may not acquire additional loan assets without the


   prior written consent of the administrative agent.




                                      101




On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

? extend the commitment termination date from February 24, 2015 to September 17,


   2017;



? extend the maturity date of the Revolving Facility from February 24, 2020 to

September 17, 2022 (unless terminated sooner upon certain events);

? reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%,

and on LIBOR borrowings from 5.50% to 4.75%; and

? reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR


   borrowings from 2.00% to 1.25%.



On May 18, 2017, we entered into a third amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

? extend the commitment termination date from September 17, 2017 to September 17,


   2020;



? extend the final maturity date of the Credit Facility from September 17, 2022


   to September 17, 2025;




? reduce the floor on base rate borrowings from 2.25% to 2.00%;

? reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

? reduce the commitment fee rate from 0.75% to 0.50% for any period during which

the ratio of advances outstanding to aggregate commitments, expressed as a

percentage, is greater than or equal to 50%.

On April 24, 2020, we entered into a fourth amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

? permit certain amendments related to the Paycheck Protection Program

("Permitted PPP Amendment") to Loan Asset Documents;

? exclude certain debt and interest amounts allowed by the Permitted PPP

Amendments from certain calculations related to Net Leverage Ratio, Interest

Coverage Ratio and EBITDA; and

? exclude such Permitted PPP Amendments from constituting a Material


   Modification.



On September 14, 2020, we entered into a fifth amendment to the Credit Facility to, among other things:

? extend the commitment termination date of the Credit Facility from September

17, 2020 to September 17, 2021, with no change to the maturity date of

September 17, 2025.




 ? provide for the transition away from the LIBOR Rate in the market, and

? expand the definition of "Eligible Loan Asset" to allow investments with

certain recurring revenue features to qualify as Collateral and be included in


   the borrowing base.




As of February 28, 2021, we had no outstanding borrowings under the Credit
Facility and $158.0 million of SBA-guaranteed debentures outstanding (which are
discussed below). As of February 29, 2020, we had no outstanding borrowings
under the Credit Facility and $150.0 million of SBA-guaranteed debentures
outstanding. Our borrowing base under the Credit Facility at February 28, 2021
and February 29, 2020 was $38.9 million and $35.6 million, respectively.



Our asset coverage ratio, as defined in the 1940 Act, was 347.1% as of February 28, 2021 and 607.1% as of February 29, 2020.





                                      102





SBA-guaranteed debentures



In addition, we, through two wholly-owned subsidiaries, sought and obtained
licenses from the SBA to operate an SBIC. In this regard, on March 28, 2012, our
wholly-owned subsidiary, Saratoga Investment Corp. SBIC LP, received a license
from the SBA to operate as an SBIC under Section 301(c) of the Small Business
Investment Act of 1958 and on August 14, 2019, our wholly-owned subsidiary,
Saratoga Investment Corp. SBIC II LP, also received a license. SBICs are
designated to stimulate the flow of private equity capital to eligible small
businesses. Under SBA regulations, SBICs may make loans to eligible small
businesses and invest in the equity securities of small businesses.



The SBIC license allows our SBIC subsidiaries to obtain leverage by issuing
SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest
only debentures with interest payable semi-annually and have a ten-year
maturity. The principal amount of SBA-guaranteed debentures is not required to
be paid prior to maturity but may be prepaid at any time without penalty. The
interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a
market-driven spread over U.S. Treasury Notes with 10-year maturities.



SBA regulations previously limited the amount that our SBIC subsidiary may
borrow to a maximum of $150.0 million when it has at least $75.0 million in
regulatory capital, receives a capital commitment from the SBA and has been
through an examination by the SBA subsequent to licensing. This maximum has been
increased by SBA regulators for new licenses to $175.0 million of SBA debentures
when it has at least $87.5 million in regulatory capital. The new license will
provide up to $175.0 million in additional long-term capital in the form of
SBA-guaranteed debentures. The SBIC LP and SBIC II LP are regulated by the SBA.
As a result of the 2016 omnibus spending bill signed into law in December 2015,
the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can
have outstanding was increased from $225.0 million to $350.0 million. Our
wholly-owned SBIC subsidiaries are able to borrow funds from the SBA against
regulatory capital (which approximates equity capital) that is paid in and is
subject to customary regulatory requirements including but not limited to an
examination by the SBA. With this license approval, Saratoga will grow its SBA
relationship from $150.0 million to $325.0 million of committed capital.



We received exemptive relief from the SEC to permit us to exclude the debt of
our SBIC subsidiaries guaranteed by the SBA from the definition of senior
securities in the asset coverage test under the 1940 Act. This allows us
increased flexibility under the asset coverage test by permitting us to borrow
up to $325.0 million more than we would otherwise be able to absent the receipt
of this exemptive relief. On April 16, 2018, as permitted by the Small Business
Credit Availability Act, which was signed into law on March 23, 2018, our
non-interested board of directors approved of our becoming subject to a minimum
asset coverage ratio of 150.0% from 200% under Sections 18(a)(1) and 18(a)(2) of
the Investment Company Act, as amended. The 150.0% asset coverage ratio became
effective on April 16, 2019.



As of February 28, 2021, our SBIC LP subsidiary had $75.0 million in regulatory
capital and $124.0 million SBA-guaranteed debentures outstanding and our SBIC II
LP subsidiary had $69.0 million in regulatory capital and $34.0 million
SBA-guaranteed debentures outstanding.



Unsecured notes



In May 2013, the Company issued $48.3 million in aggregate principal amount of
7.50% fixed-rate notes due 2020 (the "2020 Notes"). The 2020 Notes were redeemed
in full on January 13, 2017 and are no longer listed on the NYSE.



On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg
Thalmann & Co. through which we may offer for sale, from time to time, up to
$20.0 million in aggregate principal amount of the 2020 Notes through an ATM
offering. Prior to the 2020 Notes being redeemed in full, the Company had sold
539,725 bonds with a principal of $13.5 million at an average price of $25.31
for aggregate net proceeds of $13.4 million (net of transaction costs).



On December 21, 2016, we issued $74.5 million in aggregate principal amount of
our 2023 Notes for net proceeds of $71.7 million after deducting underwriting
commissions of approximately $2.3 million and offering costs of approximately
$0.5 million. The net proceeds from the offering were used to repay all of the
outstanding indebtedness under the 2020 Notes on January 13, 2017, which
amounted to $61.8 million, and for general corporate purposes in accordance with
our investment objective and strategies. On December 21, 2019 and February 7,
2020, the Company redeemed $50.0 million and $24.5 million, respectively, in
aggregate principal amount of the $74.5 million in aggregate principal amount of
issued and outstanding 2023 Notes and are no longer listed on the NYSE.



                                      103





On August 28, 2018, the Company issued $40.0 million in aggregate principal
amount of our 6.25% fixed-rate notes due 2025 (the "6.25% 2025 Notes") for net
proceeds of $38.7 million after deducting underwriting commissions of
approximately $1.3 million. Offering costs incurred were approximately $0.3
million. The issuance included the full exercise of the underwriters' option to
purchase an additional $5.0 million aggregate principal amount of 6.25% 2025
Notes within 30 days. Interest on the 6.25% 2025 Notes is paid quarterly in
arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25%
per year, beginning November 30, 2018. The 6.25% 2025 Notes mature on August 31,
2025 and commencing August 28, 2021, may be redeemed in whole or in part at any
time or from time to time at our option. The net proceeds from the offering were
used for general corporate purposes in accordance with our investment objective
and strategies. Financing costs of $1.6 million related to the 6.25% 2025 Notes
have been capitalized and are being amortized over the term of the 6.25% 2025
Notes. The 6.25% 2025 Notes are listed on the NYSE under the trading symbol
"SAF" with a par value of $25.00 per share.



On February 5, 2019, the Company completed a re-opening and up-sizing of its
existing 6.25% 2025 Notes by issuing an additional $20.0 million in aggregate
principal amount for net proceeds of $19.2 million after deducting underwriting
commissions of approximately $0.6 million and discount of $0.2 million. Offering
costs incurred were approximately $0.2 million. The issuance included the full
exercise of the underwriters' option to purchase an additional $2.5 million
aggregate principal amount of 6.25% 2025 Notes within 30 days. Interest rate,
interest payment dates and maturity remain unchanged from the existing 6.25%
2025 Notes issued in August 2018. The net proceeds from this offering were used
for general corporate purposes in accordance with our investment objective and
strategies. The financing costs and discount of $1.0 million related to the
6.25% 2025 Notes have been capitalized and are being amortized over the term of
the 6.25% 2025 Notes.


At February 28, 2021, the total 6.25% 2025 Notes outstanding was $60.0 million.

In connection with the issuance of the 6.25% 2025 Notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

? we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as

modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but

giving effect to any exemptive relief granted to us by the SEC. These

provisions generally prohibit us from making additional borrowings, including

through the issuance of additional debt or the sale of additional debt

securities, unless our asset coverage, as defined in the 1940 Act, equals at

least 200% after such borrowings, or, if we obtain the required approvals from

our independent directors and/or stockholders, 150% (after deducting the amount

of such dividend, distribution or purchase price, as the case may be).

? we will not declare any dividend (except a dividend payable in our stock), or

declare any other distribution, upon a class of our capital stock, or purchase

any such capital stock, unless, in every such case, at the time of the

declaration of any such dividend or distribution, or at the time of any such

purchase, we have an asset coverage (as defined in the 1940 Act) of at least

150.0%, as such obligation may be amended or superseded, after deducting the

amount of such dividend, distribution or purchase price, as the case may be,

and in each case giving effect to (i) any exemptive relief granted to us by the

SEC, and (ii) any SEC no-action relief granted by the SEC to another BDC (or to

us if we determine to seek such similar no-action or other relief) permitting

the BDC to declare any cash dividend or distribution notwithstanding the

prohibition contained in Section 18(a)(1)(B) as modified by such provisions of

Section 61(a) of the 1940 Act as may be applicable to us from time to time, as

such obligation may be amended or superseded, in order to maintain such BDC's

status as a regulated investment company under Subchapter M of the Code.

? if, at any time, we are not subject to the reporting requirements of Sections

13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to

file any periodic reports with the SEC, we agree to furnish to holders of the

6.25% 2025 Notes and the Trustee, for the period of time during which the 6.25%

2025 Notes are outstanding, our audited annual consolidated financial

statements, within 90 days of our fiscal year end, and unaudited interim

consolidated financial statements, within 45 days of our fiscal quarter end

(other than our fourth fiscal quarter). All such financial statements will be

prepared, in all material respects, in accordance with applicable United States


   generally accepted accounting principles.






                                      104





On June 24, 2020, the Company issued $37.5 million in aggregate principal amount
of our 7.25% fixed-rate notes due 2025 (the "7.25% 2025 Notes") for net proceeds
of $36.3 million after deducting underwriting commissions of approximately $1.2
million. Offering costs incurred were approximately $0.3 million. On July 6,
2020, the underwriters exercised their option in full to purchase an additional
$5.625 million in aggregate principal amount of its 7.25% unsecured notes due
2025. Net proceeds to the Company were $5.4 million after deducting underwriting
commissions of approximately $0.2 million. Interest on the 7.25% 2025 Notes is
paid quarterly in arrears on February 28, May 31, August 31 and November 30, at
a rate of 7.25% per year, beginning August 31, 2020. The 7.25% 2025 Notes mature
on June 30, 2025 and commencing June 24, 2022, may be redeemed in whole or in
part at any time or from time to time at our option. The net proceeds from the
offering were used for general corporate purposes in accordance with our
investment objective and strategies. Financing costs of $1.6 million related to
the 7.25% 2025 Notes have been capitalized and are being amortized over the term
of the 7.25% 2025 Notes. The Company has received an investment grade private
rating of "BBB+" from Egan-Jones Ratings Company, an independent, unaffiliated
rating agency. The 7.25% 2025 Notes are listed on the NYSE under the trading
symbol "SAK" with a par value of $25.00 per share. At February 28, 2021, the
total 7.25% 2025 Notes outstanding was $43.1 million.



On July 9, 2020, the Company issued $5.0 million aggregate principal amount of
our 7.75% fixed-rate Notes due in 2025 (the "7.75% 2025 Notes") for net proceeds
of $4.8 million after deducting underwriting commissions of approximately $0.2
million. Offering costs incurred were approximately $0.1 million. Interest on
the 7.75% Notes 2025 is paid quarterly in arrears on February 28, May 31, August
31 and November 30, at a rate of 7.75% per year, beginning August 31, 2020. The
7.75% Notes 2025 mature on July 9, 2025 and may be redeemed in whole or in part
at any time or from time to time at our option. The net proceeds from the
offering were used for general corporate purposes in accordance with our
investment objective and strategies. Financing costs of $0.3 million related to
the 7.75% Notes 2025 have been capitalized and are being amortized over the term
of the Notes. The 7.75% 2025 Notes are unlisted and have a par value of $25.00
per share.


At February 28, 2021, the total 7.75% 2025 Notes outstanding was $5.0 million.


On December 29, 2020, the Company issued $5.0 aggregate principal amount of our
6.25% fixed-rate Notes due in 2027 (the "6.25% Notes 2027"). Offering costs
incurred were approximately $0.1 million. Interest on the 6.25% Notes 2027 is
paid quarterly in arrears on February 28, May 31, August 31 and November 30, at
a rate of 6.25% per year, beginning February 28, 2021. The 6.25% Notes 2027
mature on December 29, 2027 and may be redeemed in whole or in part at any time
or from time to time at our option, on or after December 29, 2024. The net
proceeds from the offering were used for general corporate purposes in
accordance with our investment objective and strategies. Financing costs of
$0.1 million related to the 6.25% Notes 2027 have been capitalized and are being
amortized over the term of the Notes.



On January 28, 2021, the Company issued $10.0m aggregate principal amount of our
6.25% fixed rate Notes due in 2027 (the "Second 6.25% Notes 2027") for net
proceeds of $9.7 million after deducting underwriting commissions of
approximately $0.3 million. Offering costs incurred were approximately $0.0
million. Interest on the 6.25% Notes 2027 is paid quarterly in arrears on
February 28, May 31, August 31 and November 30, at a rate of 6.25% per year,
beginning February 28, 2021. The 6.25% Notes 2027 mature on January 28, 2027 and
commencing January 28, 2023, may be redeemed in whole or in part at any time or
from time to time at our option. The net proceeds from the offering were used
for general corporate purposes in accordance with our investment objective and
strategies. Financing costs of $0.3 million related to the 6.25% Notes 2027 have
been capitalized and are being amortized over the term of the Notes.



At February 28, 2021, the total 6.25% 2025 Notes outstanding was $15.0 million.

At February 28, 2021 and February 29, 2020, the fair value of total cash and cash equivalents, cash and cash equivalents in reserve accounts and total investments by major category are as follows:





                                                    February 28, 2021                  February 29, 2020
                                                              Percentage of                      Percentage of
                                              Fair Value          Total          Fair Value          Total
                                                                      ($ in

thousands)


Cash and cash equivalents                     $    18,828                3.2 %   $    24,599                4.7 %
Cash and cash equivalents, reserve accounts        11,087                1.9          14,851                2.8
First lien term loans                             440,456               75.4         346,233               66.0
Second lien term loans                             24,930                4.3          73,570               14.0
Unsecured term loans                                2,141                0.4           4,346                0.8
Structured finance securities                      49,779                8.5          32,470                6.2
Equity interests                                   37,007                6.3          29,013                5.5
Total                                         $   584,228              100.0 %   $   525,082              100.0 %




                                      105





On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced
at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75
million. The net proceeds, after deducting underwriting commissions of $1.15
million and offering costs of approximately $0.2 million, amounted to
approximately $27.4 million. The Company also granted the underwriters a 30-day
option to purchase up to an additional 172,500 shares of its common stock,

which
was not exercised.



On March 16, 2017, we entered into an equity distribution agreement with
Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to
time, up to $30.0 million of our common stock through an ATM offering.
Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added
to the agreement. On July 9, 2019, the amount of the common stock to be offered
through this offering was increased to $70.0 million, and on October 8, 2019,
the amount of the common stock to be offered was increased to $130.0 million. As
of February 28, 2021, the Company sold 3,922,018 shares for gross proceeds of
$97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9
million (net of transaction costs). For the year ended February 28, 2021, there
was no activity related to the ATM offerings.



On September 24, 2014, the Company announced the approval of an open market
share repurchase plan that allowed it to repurchase up to 200,000 shares of its
common stock at prices below its NAV as reported in its then most recently
published consolidated financial statements (the "Share Repurchase Plan"). On
October 7, 2015, our board of directors extended the Share Repurchase Plan for
another year and increased the number of shares the Company is permitted to
repurchase at prices below its NAV, as reported in its then most recently
published consolidated financial statements, to 400,000 shares of its common
stock. On October 5, 2016, our board of directors extended the Share Repurchase
Plan for another year to October 15, 2017 and increased the number of shares the
Company is permitted to repurchase at prices below its NAV, as reported in its
then most recently published consolidated financial statements, to 600,000
shares of its common stock. On October 10, 2017, January 8, 2019 and January 7,
2020, our board of directors extended the Share Repurchase Plan for another year
to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each
time leaving the number of shares unchanged at 600,000 shares of its common
stock. On May 4, 2020, our board of directors increased the Share Repurchase
Plan to 1.3 million shares of common stock. On January 5, 2021, our board of
directors extended the Shares Repurchase Plan for another year to January 15,
2022, leaving the number of shares unchanged at 1.3 million shares of common
stock. As of February 28, 2021, the Company purchased 408,812 shares of common
stock, at the average price of $17.84 for approximately $7.3 million pursuant to
the Share Repurchase Plan. During the year ended February 28, 2021 the Company
purchased 190,321 shares of common stock, at the average price $18.96 for
approximately $3.6 million pursuant to the Share Repurchase Plan.



On January 5, 2021, our board of directors declared a dividend of $0.42 per
share, which was paid on February 10, 2021, to common stockholders of record as
of January 26, 2021. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $3.8 million
in cash and 41,388 newly issued shares of common stock, or 0.4% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$21.75 per share, which equaled 95% of the volume weighted average trading price
per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5,

8, 9
and 10, 2021.



On October 7, 2020, our board of directors declared a dividend of $0.41 per
share, which was paid on November 10, 2020, to common stockholders of record as
of October 26, 2020. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $3.8 million
in cash and 45,706 newly issued shares of common stock, or 0.4% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$17.63 per share, which equaled 95% of the volume weighted average trading price
per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6,
9 and 10, 2020.



On July 7, 2020, the Company declared a dividend of $0.40 per share payable on
August 12, 2020, to common stockholders of record on July 27, 2020. Shareholders
have the option to receive payment of the dividend in cash, or receive shares of
common stock, pursuant to the Company's DRIP. Based on shareholder elections,
the dividend consisted of approximately $3.7 million in cash and 47,098 newly
issued shares of common stock, or 0.4% of our outstanding common stock prior to
the dividend payment. The number of shares of common stock comprising the stock
portion was calculated based on a price of $16.45 per share, which equaled 95.0%
of the volume weighted average trading price per share of the common stock on
July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.



During the three months ended May 31, 2020, there were no dividends declared.





                                      106





On January 7, 2020, the Company declared a dividend of $0.56 per share, which
was paid on February 6, 2020, to common stockholders of record on January 24,
2020. Shareholders had the option to receive payment of the dividend in cash, or
receive shares of common stock, pursuant to the Company's DRIP. Based on
shareholder elections, the dividend consisted of approximately $5.4 million in
cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $25.44 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3,

4, 5
and 6, 2020.



On August 27, 2019, the Company declared a dividend of $0.56 per share, which
was paid on September 26, 2019, to common stockholders of record on
September 13, 2019. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the Company's
DRIP. Based on shareholder elections, the dividend consisted of approximately
$4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of
our outstanding common stock prior to the dividend payment. The number of shares
of common stock comprising the stock portion was calculated based on a price of
$23.34 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24,
25 and 26, 2019.



On May 28, 2019, our board of directors declared a dividend of $0.55 per share,
which was paid on June 27, 2019, to common stockholders of record as of June 13,
2019. Shareholders had the option to receive payment of the dividend in cash, or
receive shares of common stock, pursuant to the DRIP. Based on shareholder
elections, the dividend consisted of approximately $3.6 million in cash and
31,545 newly issued shares of common stock, or 0.4% of our outstanding common
stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $22.65 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27,
2019.



On February 26, 2019, our board of directors declared a dividend of $0.54 per
share, which was paid on March 28, 2019, to common stockholders of record as of
March 14, 2019. Shareholders had the option to receive payment of the dividend
in cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $3.5 million in
cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $21.36 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28,
2019.



On November 27, 2018, our board declared a dividend of $0.53 per share payable
on January 2, 2019, to common stockholders of record on December 17, 2018.
Shareholders had the option to receive payment of the dividend in cash, or
receive shares of common stock, pursuant to the Company's DRIP. Based on
shareholder elections, the dividend consisted of approximately $3.4 million in
cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $18.88 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018
and January 2, 2019.



On August 28, 2018, our board of directors declared a dividend of $0.52 per
share, which was paid on September 27, 2018, to common stockholders of record as
of September 17, 2018. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $3.3 million
in cash and 25,862 newly issued shares of common stock, or 0.3% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$22.35 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25,
26 and 27, 2018.



On May 30, 2018, our board of directors declared a dividend of $0.51 per share,
which was paid on June 27, 2018, to common stockholders of record as of June 15,
2018. Shareholders had the option to receive payment of the dividend in cash, or
receive shares of common stock, pursuant to the DRIP. Based on shareholder
elections, the dividend consisted of approximately $2.7 million in cash and
21,562 newly issued shares of common stock, or 0.3% of our outstanding common
stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $23.72 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27,
2018.



                                      107





On February 26, 2018, our board of directors declared a dividend of $0.50 per
share, which was paid on March 26, 2018, to common stockholders of record as of
March 14, 2018. Shareholders had the option to receive payment of the dividend
in cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $2.6 million in
cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $19.91 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26,
2018.



On November 29, 2017, our board of directors declared a dividend of $0.49 per
share payable on December 27, 2017, to common stockholders of record on December
15, 2017. Shareholders had the option to receive payment of the dividend in
cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $2.5 million in
cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $21.14 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27,
2017.



On August 28, 2017, our board of directors declared a dividend of $0.48 per
share payable on September 26, 2017, to common stockholders of record on
September 15, 2017. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $2.2 million
in cash and 33,551 newly issued shares of common stock, or 0.6% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$20.19 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22,
25 and 26, 2017.



On May 30, 2017, our board of directors declared a dividend of $0.47 per share
which was paid on June 27, 2017, to common stockholders of record on June 15,
2017. Shareholders had the option to receive payment of the dividend in cash, or
receive shares of common stock, pursuant to the DRIP. Based on shareholder
elections, the dividend consisted of approximately $2.3 million in cash and
26,222 newly issued shares of common stock, or 0.4% of our outstanding common
stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $20.04 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27,
2017.



On February 28, 2017, our board of directors declared a dividend of $0.46 per
share, which was paid on March 28, 2017, to common stockholders of record as of
March 15, 2017. Shareholders had the option to receive payment of the dividend
in cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $2.0 million in
cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $21.38 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28,
2017.



On January 12, 2017, our board of directors declared a dividend of $0.45 per
share, which was paid on February 9, 2017, to common stockholders of record as
of January 31, 2017. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $1.6 million
in cash and 50,453 newly issued shares of common stock, or 0.9% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$20.25 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on January 27, 30, 31 and February 1, 2, 3,
6, 7, 8 and 9, 2017.



On October 5, 2016, our board of directors declared a dividend of $0.44 per
share, which was paid on November 9, 2016, to common stockholders of record as
of October 31, 2016. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $1.5 million
in cash and 58,548 newly issued shares of common stock, or 1.0% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$17.12 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on October 27, 28, 31 and November 1, 2, 3,
4, 7, 8 and 9, 2016.



                                      108





On August 8, 2016, our board of directors declared a special dividend of $0.20
per share, which was paid on September 5, 2016, to common stockholders of record
as of August 24, 2016. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $0.7 million
in cash and 24,786 newly issued shares of common stock, or 0.4% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$17.06 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and
September 1 and 2, 2016.



On July 7, 2016, our board of directors declared a dividend of $0.43 per share,
which was paid on August 9, 2016, to common stockholders of record as of July
29, 2016. Shareholders had the option to receive payment of the dividend in
cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $1.5 million in
cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $16.32 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9,
2016.



On March 31, 2016, our board of directors declared a dividend of $0.41 per
share, which was paid on April 27, 2016, to common stockholders of record as of
April 15, 2016. Shareholders had the option to receive payment of the dividend
in cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $1.5 million in
cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $15.43 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27,
2016.



On January 12, 2016, our board of directors declared a dividend of $0.40 per
share, which was paid on February 29, 2016, to common stockholders of record as
of February 1, 2016. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $1.4 million
in cash and 66,765 newly issued shares of common stock, or 1.2% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$13.11 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24,

25,
26 and 29, 2016.



On October 7, 2015, our board of directors declared a dividend of $0.36 per
share, which was paid on November 30, 2015, to common stockholders of record as
of November 2, 2015. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $1.1 million
in cash and 61,029 newly issued shares of common stock, or 1.1% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$14.53 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24,

25,
27 and 30, 2015.



On July 8, 2015, our board of directors declared a dividend of $0.33 per share,
which was paid on August 31, 2015, to common stockholders of record as of August
3, 2015. Shareholders had the option to receive payment of the dividend in cash,
or receive shares of common stock, pursuant to the DRIP. Based on shareholder
elections, the dividend consisted of approximately $1.1 million in cash and
47,861 newly issued shares of common stock, or 0.9% of our outstanding common
stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $15.28 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and

31,
2015.



On May 14, 2015, our board of directors declared a special dividend of $1.00 per
share, which was paid on June 5, 2015, to common stockholders of record on as of
May 26, 2015. Shareholders had the option to receive payment of the dividend in
cash, or receive shares of common stock, pursuant to the DRIP. Based on
shareholder elections, the dividend consisted of approximately $3.4 million in
cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding
common stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $16.47 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5,
2015.



                                      109





On April 9, 2015, our board of directors declared a dividend of $0.27 per share,
which was paid on May 29, 2015, to common stockholders of record as of May 4,
2015. Shareholders had the option to receive payment of the dividend in cash, or
receive shares of common stock, pursuant to the DRIP. Based on shareholder
elections, the dividend consisted of approximately $0.9 million in cash and
33,766 newly issued shares of common stock, or 0.6% of our outstanding common
stock prior to the dividend payment. The number of shares of common stock
comprising the stock portion was calculated based on a price of $16.78 per
share, which equaled 95.0% of the volume weighted average trading price per
share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29,
2015.



On September 24, 2014, our board of directors declared a dividend of $0.22 per
share, which was paid on February 27, 2015, to common stockholders of record on
February 2, 2015. Shareholders have the option to receive payment of the
dividend in cash, or receive shares of common stock, pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $0.8 million
in cash and 26,858 newly issued shares of common stock, or 0.5% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$14.97 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24,

25,
26 and 27, 2015.



Also, on September 24, 2014, our board of directors declared a dividend of $0.18
per share, which was paid on November 28, 2014, to common stockholders of record
on November 3, 2014. Shareholders had the option to receive payment of the
dividend in cash, or receive shares of common stock pursuant to the DRIP. Based
on shareholder elections, the dividend consisted of approximately $0.6 million
in cash and 22,283 newly issued shares of common stock, or 0.4% of our
outstanding common stock prior to the dividend payment. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$14.37 per share, which equaled 95.0% of the volume weighted average trading
price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24,

25,
26 and 28, 2014.



On October 30, 2013, our board of directors declared a dividend of $2.65 per
share, which was paid on December 27, 2013, to common stockholders of record as
of November 13, 2013. Shareholders had the option to receive payment of the
dividend in cash, shares of common stock, or a combination of cash and shares of
common stock, provided that the aggregate cash payable to all shareholders was
limited to approximately $2.5 million or $0.53 per share. This dividend was
declared in reliance on certain private letter rulings issued by the IRS
concluding that a RIC may treat a distribution of its own stock as fulfilling
its RIC distribution requirements if each stockholder may elect to receive his
or her entire distribution in either cash or stock of the RIC subject to a
limitation on the aggregate amount of cash to be distributed to all
stockholders, which limitation must be at least 20.0% of the aggregate declared
distribution. Based on shareholder elections, the dividend consisted of
approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7%
of our outstanding common stock prior to the dividend payment. The amount of
cash elected to be received was greater than the cash limit of 20.0% of the
aggregate dividend amount, thus resulting in the payment of a combination of
cash and stock to shareholders who elected to receive cash. The number of shares
of common stock comprising the stock portion was calculated based on a price of
$15.439 per share, which equaled the volume weighted average trading price per
share of the common stock on December 11, 13 and 16, 2013.



On November 9, 2012, our board of directors declared a dividend of $4.25 per
share, which was paid on December 31, 2012, to common stockholders of record as
of November 20, 2012. Shareholders had the option to receive payment of the
dividend in cash, shares of common stock, or a combination of cash and shares of
common stock, provided that the aggregate cash payable to all shareholders was
limited to approximately $3.3 million or $0.85 per share. Based on shareholder
elections, the dividend consisted of $3.3 million in cash and 853,455 shares of
common stock, or 22.0% of our outstanding common stock prior to the dividend
payment. The amount of cash elected to be received was greater than the cash
limit of 20.0% of the aggregate dividend amount, thus resulting in the payment
of a combination of cash and stock to shareholders who elected to receive cash.
The number of shares of common stock comprising the stock portion was calculated
based on a price of $15.444 per share, which equaled the volume weighted average
trading price per share of the common stock on December 14, 17 and 19, 2012.



On November 15, 2011, our board of directors declared a dividend of $3.00 per
share, which was paid on December 30, 2011, to common stockholders of record as
of November 25, 2011. Shareholders had the option to receive payment of the
dividend in cash, shares of common stock, or a combination of cash and shares of
common stock, provided that the aggregate cash payable to all shareholders was
limited to $2.0 million or $0.60 per share. Based on shareholder elections, the
dividend consisted of $2.0 million in cash and 599,584 shares of common stock,
or 18.0% of our outstanding common stock prior to the dividend payment. The
amount of cash elected to be received was greater than the cash limit of 20.0%
of the aggregate dividend amount, thus resulting in the payment of a combination
of cash and stock to shareholders who elected to receive cash. The number of
shares of common stock comprising the stock portion was calculated based on a
price of $13.117067 per share, which equaled the volume weighted average trading
price per share of the common stock on December 20, 21 and 22, 2011.



                                      110





On November 12, 2010, our board of directors declared a dividend of $4.40 per
share to shareholders payable in cash or shares of our common stock, in
accordance with the provisions of the IRS Revenue Procedure 2010-12, which
allows a publicly-traded regulated investment company to satisfy its
distribution requirements with a distribution paid partly in common stock
provided that at least 10.0% of the distribution is payable in cash. The
dividend was paid on December 29, 2010 to common shareholders of record on
November 19, 2010. Based on shareholder elections, the dividend consisted of
$1.2 million in cash and 596,235 shares of common stock, or 22.0% of our
outstanding common stock prior to the dividend payment. The amount of cash
elected to be received was greater than the cash limit of 10.0% of the aggregate
dividend amount, thus resulting in the payment of a combination of cash and
stock to shareholders who elected to receive cash. The number of shares of
common stock comprising the stock portion was calculated based on a price of
$17.8049 per share, which equaled the volume weighted average trading price per
share of the common stock on December 20, 21 and 22, 2010.



On November 13, 2009, our board of directors declared a dividend of $18.25 per
share, which was paid on December 31, 2009, to common stockholders of record as
of November 25, 2009. Shareholders had the option to receive payment of the
dividend in cash, shares of common stock, or a combination of cash and shares of
common stock, provided that the aggregate cash payable to all shareholders was
limited to $2.1 million or $0.25 per share. Based on shareholder elections, the
dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock,
or 104.0% of our outstanding common stock prior to the dividend payment. The
amount of cash elected to be received was greater than the cash limit of 13.7%
of the aggregate dividend amount, thus resulting in the payment of a combination
of cash and stock to shareholders who elected to receive cash. The number of
shares of common stock comprising the stock portion was calculated based on a
price of $1.5099 per share, which equaled the volume weighted average trading
price per share of the common stock on December 24 and 28, 2009.



We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.





Contractual obligations


The following table shows our payment obligations for repayment of debt and other contractual obligations at February 28, 2021:





                                                                  Payment Due by Period
                                                   Less Than         1 - 3         3 - 5       More Than

Long-Term Debt Obligations           Total          1 Year           Years 

Years 5 Years


                                                              ($ in thousands)
Revolving credit facility          $       -     $           -     $       -     $       -     $        -
SBA debentures                       158,000                 -        14,000        39,000        105,000
6.25% 2025 Notes                      60,000                 -             -        60,000              -
7.25% 2025 Notes                      43,125                 -             -        43,125              -
7.75% 2025 Notes                       5,000                 -             -         5,000              -
6.25% 2027 Notes                      15,000                 -             -             -         15,000
Total Long-Term Debt Obligations   $ 281,125     $           -     $  14,000     $ 147,125     $  120,000

Off-balance sheet arrangements


At February 28, 2021 and February 29, 2020, the Company's off-balance sheet
arrangements consisted of $58.8 million and $64.1 million, respectively, of
unfunded commitments outstanding to provide debt financing to its portfolio
companies or to fund limited partnership interests. Such commitments are
generally up to the Company's discretion to approve, or the satisfaction of
certain financial and nonfinancial covenants and involve, to varying degrees,
elements of credit risk in excess of the amount recognized in the Company's
consolidated statements of assets and liabilities and are not reflected in the
Company's consolidated statements of assets and liabilities.



                                      111




A summary of the unfunded commitments outstanding as of February 28, 2021 and February 29, 2020 is shown in the table below (dollars in thousands):





                                                                February 28,       February 29,
                                                                    2021               2020
At Company's discretion
Book4Time, Inc.                                                $        2,000     $            -
CLEO Communications Holding, LLC                                          630                  -
GreyHeller LLC                                                         15,000                  -
inMotionNow, Inc.                                                           -              3,000
Netreo Holdings, LLC                                                   10,000                  -
Omatic Software, LLC                                                        -              1,000
Passageways, Inc.                                                       5,000              5,000
PDDS Buyer, LLC                                                             -              5,000

Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd.                      -             17,500
Top Gun Pressure Washing, LLC                                           3,175              5,000
Village Realty Holdings LLC                                            10,000             10,000
Total                                                                  45,805             46,500

At portfolio company's discretion - satisfaction of certain
financial and nonfinancial covenants required
ArbiterSports, LLC                                                          -              1,000
Axiom Purchaser, Inc.                                                       -              1,000
CoConstruct, LLC                                                            -              3,500
Davisware, LLC                                                              -              2,000
GoReact                                                                 2,000              2,000
Granite Comfort, LP                                                         -                  -
HemaTerra Holding Company, LLC                                          2,000              4,000
New England Dental Partners                                             6,000                  -
Passageways, Inc.                                                       2,000              3,000
Procurement Partners, LLC                                               1,000                  -
Village Realty Holdings LLC                                                 -              1,124
                                                                       13,000             17,624
Total                                                          $       58,805     $       64,124




Recent Developments


Saratoga Investment Corp. announced on March 10, 2021, that it has closed a
public offering of $50.0 million aggregate principal amount of its 4.375% notes
due 2026 (the "Notes"), which resulted in net proceeds to the Company of
approximately $48.8 million based on a public offering price of 100% of the
aggregate principal amount of the Notes, after deducting payment of underwriting
discounts and commissions and estimated offering expenses payable by the
Company.



The Notes will mature on February 28, 2026, and may be redeemed in whole or in
part at any time or from time to time at the Company's option at par plus a
"make-whole" premium, if applicable. The Notes will bear interest at a rate of
4.375% per year payable semi-annually on February 28 and August 28 of each

year,
beginning August 28, 2021.



On March 22, 2021, the Company declared a dividend of $0.43 per share payable on
April 22, 2021, to common stockholders of record on April 8, 2021. Shareholders
have the option to receive payment of the dividend in cash, or receive shares of
common stock, pursuant to the Company's DRIP. Based on shareholder elections,
the dividend consisted of approximately $3.9 million in cash and 38,580 newly
issued shares of common stock, or 0.3% of our outstanding common stock prior to
the dividend payment. The number of shares of common stock comprising the stock
portion was calculated based on a price of $23.69 per share, which equaled 95%
of the volume weighted average trading price per share of the common stock on
April 9, 12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.



Subsequent to February 28, 2021, the global outbreak of the coronavirus pandemic
has adversely affected some of the Company's investments and continues to have
adverse consequences on the U.S. and global economies. The ultimate economic
fallout from the pandemic, and the long-term impact on economies, markets,
industries and individual portfolio companies, remains uncertain. At the time of
this filing, there is no indication of a reportable subsequent event impacting
the Company's financial statements for the year ended February 28, 2021. The
Company cannot predict the extent to which its financial condition and results
of operations will be adversely affected at this time. The potential impact to
our results will depend to a large extent on future developments and new
information that may emerge regarding the duration and severity of COVID-19. The
Company continues to observe and respond to the evolving COVID-19 environment
and its potential impact on areas across its business.



                                      112

© Edgar Online, source Glimpses